DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	TNFRSF13B; LILRA1; TSPAN12; EGFR; PRL; IFNG; IL2RA; ERBB2; MET; CD3G; NPR1; EDN2; EPHA1; CXCR1; BDKRB2; GLP1R; P2RY1; CCR5; ADGRE1; GPR157; ADGRG6; ADGRF5; LILRB2; CLEC1A; ADGRV1; MAGI1; ADGRE3; ADGRL4; CLEC1B; CLEC4A; TRBV19; TRBV5-1; CD80; TRBV5-5; TRBV3-1; TRBV2; TRBV13; TRBV28; TRBV11-1; TRBV25-1; TRBV11-3; TRBV7-6; TRBV29-1; TRBV14; TRBV20-1; TRBV7-4; TRBV12-5; TRBV6-5; TRBV12-4; TRBV5-6; TRBV23-1; ANXA1; TRBV18; TRBV7-9;	GO:0007166~cell surface receptor signaling pathway	54	268	20.1492537313433	0	0	0	0	0	0	0
down	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; C1R; C3; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; C1QA; C1QC; C4BPA; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; CFI; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; PROS1; C1S; IGLC2; IGLC3; C7; CD19; IGHV1-2; IGLV3-21; SUSD4;	GO:0030449~regulation of complement activation	66	113	58.4070796460177	0	0	0	0	0	0	0
down	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; WIPF3; WASL; PLD2; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; CD3G; IGLC2; IGLC3; FCGR2A; IGHV1-2; FCGR2B; NCKAP1L; IGLV3-21; BAIAP2; NCKAP1;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	64	135	47.4074074074074	0	0	0	0	0	0	0
down	IGKV2-28; IGKV2D-30; TRAV19; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; CD300LB; LILRA1; NCR1; C3; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; TRAV8-4; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; TRBV7-9; CD1A; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; CD3G; IGLC2; IGLC3; CD8B; CD19; VCAM1; IGHV1-2; CD1B; CD1C; CD40LG; FCGR2B; ICAM3; KIR2DL1; KIR2DL3; CXADR; IGLV3-21; CD300E; COLEC12; TREML2; TREML4; CD300LD; LILRB2; LILRB1; RAET1E; CD300LF; CD300A; SIGLEC7; BTNL8; BTNL3; BTN1A1; HHLA2;	GO:0050776~regulation of immune response	88	216	40.7407407407407	0	0	0	0	0	0	0
down	MS4A1; CD19; CTLA4; MNDA; NCKAP1L; IGHV4-34; IGHV4-4; IGHV4-61; IGHV3-33; IGHV3-11; IGHV3-72; IGHV3-21; IGHV4-28; IGHV4-39; IGHV1-69-2; IGHV1-2; IGHV2-70; IGHV2-5; IGHV2-26; IGLC3; IGHV3-43; IGHV3-30; IGHV3-13; TRBC2; IGHV5-51; IGHG2; IGHV3-23; IGHV1-3; IGHV1-69; IGHV3-73; IGHV1-46; IGHV4-59; IGHV3-64; IGHV6-1; IGHV1-45; IGHG3; IGHV1-18; IGHV1-24; IGLC7; IGHA2; IGHV3-74; IGHV3-20; IGHD; IGHV3-15; IGHV3-66; IGHV3-48; IGLC2; IGHV4-31; IGHV1-58; IGHV3-53; IGHV3-49; IGHV3-7; IGKC;	GO:0050853~B cell receptor signaling pathway	53	125	42.4	0	0	0	0	0	0	0
down	PRMT5; EGFR; ERBB2; GSTP1; CEACAM1; EPHA2; ARHGEF5; FAM83D;	GO:0070372~regulation of ERK1 and ERK2 cascade	8	29	27.5862068965517	0.00011703577774602	0.00544096942255995	0.521862532969511	0.533215003410875	0.388207674783554	0.521862532969511	0.048977026257912
down	AKR1C3; AKR1C1; RDH10; SDR16C5; RDH13; BCO2;	GO:0042574~retinal metabolic process	6	14	42.8571428571429	0.00012132001850062	0.00552734004288851	0.540723322457289	0.552734004288851	0.395381940293539	0.540723322457289	0.0497544936191886
down	PANO1; WNT10B; UNC13B; MCF2L; KALRN; S100B; NGFR; RARB; TOP2A; BMP4; RARG; HPGD; CTLA4; BMP7; PTN; MNDA; FOXA1; EEF1A2; ARHGEF5; MELK; PLEKHN1; PHLDA2; NGEF; LILRB1; FRZB; FAM162A; SFRP2; ARHGEF4; PHLDA3; SCIN; SCIMP;	GO:0043065~positive regulation of apoptotic process	31	332	9.33734939759036	0.00014883964219558	0.0066250667223393	0.663080605981337	0.678113409843091	0.440714180541131	0.663080605981337	0.0596357085696994
down	LILRA5; IFNG; ORM1; LPL; ORM2; MMP8; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	7	22	31.8181818181818	0.00014977653037773	0.0066250667223393	0.667104666302419	0.682381872400947	0.442126351348289	0.667104666302419	0.0596357085696994
up	S100A8; S100A9; S100A12; CRNN;	GO:0051092~positive regulation of NF-kappaB transcription factor activity	4	154	2.5974025974026	0.00015380007268828	0.00430640203527188	0.0416798196985243	0.0430640203527188	0.0409108193350829	0.0416798196985243	0.0267590775557968
down	ZBTB7C; PTGES; EREG; ALOX15B; KLF4; SPRY1; NTRK1; RARB; BMP4; RARG; OSM; GATA1; CD9; MSX1; AVPR2; SSTR3; CDKN2B; RIPPLY3; PMP22; DHCR24; CDKN3; BNIPL; MYOCD; RXFP2; FRZB; DLG3; RERG; SFRP2; NDN; CDC6; SOX7; DLL4; SIRPG; SCIN; BTG3;	GO:0008285~negative regulation of cell population proliferation	35	396	8.83838383838384	0.00015600046440689	0.00680577227184209	0.694670068003887	0.710738115837797	0.451137552122341	0.694670068003887	0.0612623342232552
down	TULP1; JCHAIN; IGKC; IGHG3; IGHA2; TF; KRT1; HSPB1; PRDX1;	GO:0001895~retina homeostasis	9	40	22.5	0.00016862535497996	0.00717315050280309	0.750382829660856	0.768257117288733	0.46742948400447	0.750382829660856	0.0645692988222028
down	ZWINT; NEK2; PLK1; ESPL1; SPAG5; KIFC1; CDCA8; KIF18B;	GO:0000070~mitotic sister chromatid segregation	8	31	25.8064516129032	0.00017318844497549	0.00717315050280309	0.770515391695963	0.78904655530834	0.473135644347661	0.770169014806012	0.0645692988222028
down	EGFR; BDNF; GNA15; AVPR1A; NTRK2; P2RY12; NMUR1; GPR55;	GO:0007202~activation of phospholipase C activity	8	31	25.8064516129032	0.00017318844497549	0.00717315050280309	0.770515391695963	0.78904655530834	0.473135644347661	0.770169014806012	0.0645692988222028
down	CCNB1; TAL1; DYNLT3; FOXA1; LGMN; SMOC2; CDC25C; CDC25A;	GO:0045931~positive regulation of mitotic cell cycle	8	31	25.8064516129032	0.00017318844497549	0.00717315050280309	0.770515391695963	0.78904655530834	0.473135644347661	0.770169014806012	0.0645692988222028
down	AURKA; MAP3K13; EGFR; ERBB2; NTRK1; KIT; EPHA1; FGFR4; FGFR3; TTK; FLT4; KDR; FLT3; NEK2; EPHB3; TYRO3; PTK6; MELK; NTRK2; AURKB;	GO:0046777~protein autophosphorylation	20	173	11.5606936416185	0.00017862440500371	0.00733164674952178	0.79416410464651	0.813812789196918	0.479864195792848	0.79416410464651	0.0659960068652834
up	PIGR; S100A8; S100A9; FCER1G; S100A11; S100A12;	GO:0043312~neutrophil degranulation	6	483	1.24223602484472	0.00018553428026324	0.00434860059277176	0.0500942556710759	0.0519495984737084	0.0480533785881803	0.0500942556710759	0.0270212905270041
up	S100A9; S100A12; CXCL11;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	3	62	4.83870967741935	0.00018636859683307	0.00434860059277176	0.0501331525480972	0.0521832071132611	0.0481423165709385	0.0501331525480972	0.0270212905270041
down	TRPM2; VCAM1; KDR; PTGFR; DEFB1; CCL20; HOMER2;	GO:0035584~calcium-mediated signaling using intracellular calcium source	7	23	30.4347826086957	0.00018835824898966	0.00752772089821841	0.837064058510057	0.858160182396899	0.490315656725955	0.836875700261067	0.0677609733599296
down	PRMT5; PTN; PPARG; ASPA; OLIG2; IL34; ZNF488;	GO:0048714~positive regulation of oligodendrocyte differentiation	7	23	30.4347826086957	0.00018835824898966	0.00752772089821841	0.837064058510057	0.858160182396899	0.490315656725955	0.836875700261067	0.0677609733599296
down	CNN1; TJP1; MYH14; LIMCH1; EPB41L5; CIT; EPB41L1; CDC42BPG;	GO:0031032~actomyosin structure organization	8	32	25	0.00020862215606287	0.00812378241899543	0.926282372919172	0.950482543022465	0.512062371335306	0.926282372919172	0.0731264364763703
down	AURKA; KLF4; IFNG; BMP4; CCNB1; MMP8; ITGB8; KDR; OPRD1; XDH; PRKAA2; AIF1; WNT4; IQGAP3; SFRP2; ATOH8; LGMN; CCDC3; UPK3B; DLL4; NDFIP2; HEY2;	GO:0010629~negative regulation of gene expression	22	204	10.7843137254902	0.00021563866579066	0.00825341319469729	0.957220037444752	0.98244976134226	0.519582452921409	0.957220037444752	0.0742933112393599
down	CNTN1; SCN5A; CNKSR3; GPD1L; PKP2; PRSS8;	GO:0010765~positive regulation of sodium ion transport	6	16	37.5	0.00021738577334584	0.00825341319469729	0.96454067633552	0.990409583363675	0.521498269737442	0.96454067633552	0.0742933112393599
down	PLK1; CDC20; TRIP13; AURKB; TTK; BUB1; BUB1B;	GO:0007094~mitotic spindle assembly checkpoint	7	24	29.1666666666667	0.00023458143153687	0.00861897582324189	1	1	0.539875668206444	0.999989987113883	0.0775839326464393
down	BMP4; SOX8; PPARD; IL18; SOSTDC1; CCL17; CMTM5;	GO:0045662~negative regulation of myoblast differentiation	7	24	29.1666666666667	0.00023458143153687	0.00861897582324189	1	1	0.539875668206444	0.999989987113883	0.0775839326464393
down	MATN2; CHL1; OPHN1; NFASC; SPTA1; NTRK1; NGFR; BMP7; BDNF; EPHB3; GRB7; SEMA3A; NECTIN1; DOK4; NRTN; EPHA3; EFNA5; UNC5B; EPHA2; ROBO4; EPHA1; EPHA6;	GO:0007411~axon guidance	22	206	10.6796116504854	0.00024421139360575	0.0089010168741425	1	1	0.550208269793762	0.999989987113883	0.0801227324232755
down	IL2RA; CTLA4; SDC4; DLG1; LILRB2; LILRB1; FOXJ1; PLA2G2D; CD80;	GO:0042130~negative regulation of T cell proliferation	9	43	20.9302325581395	0.00026992726601138	0.00945991249190661	1	1	0.573369419542656	0.999989987113883	0.0851536457074355
down	GCAT; GGT5; PTS; PM20D1; KYAT3; PHGDH;	GO:0006520~cellular amino acid metabolic process	6	17	35.2941176470588	0.00028376845088651	0.00986907681098435	1	1	0.583678749728511	0.999989987113883	0.0888367488537573
down	CLDN4; KRT1; MET; ALOX12; SFN; TMEM79; GRHL1;	GO:0061436~establishment of skin barrier	7	25	28	0.00028951647756692	0.00999270508935521	1	1	0.587907562094581	0.999989987113883	0.0899495919825726
down	SLC22A31; GJB3; ABCA8; SLCO2B1; SLC25A5; GJB2; SLC6A1; SLC6A4; SLC18A1; OCA2; SLC10A6; SLC23A3; SLC16A14; SLC16A9; SLC47A2; SPNS2; LRRC8A; SLC44A3; SLC44A5; PSMA8; SLC25A43; SLCO4A1; SLC47A1; SLC25A21; SLC17A9; STEAP1; GJA3;	GO:0055085~transmembrane transport	27	285	9.47368421052632	0.00031127959518095	0.0106630814710109	1	1	0.603959606216478	0.999989987113883	0.0959840022313963
down	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.0003194210048858	0.0108603141661172	1	1	0.609713853035921	0.999989987113883	0.0977593974113601
up	S100A9; GPX2; HBG2;	GO:0098869~cellular oxidant detoxification	3	77	3.8961038961039	0.00034420511913624	0.00666416793020967	0.0919027668093768	0.096377433358148	0.0788229722821996	0.0919027668093768	0.0414097395061434
down	EREG; SPRY1; EGFR; TGFA; PTPN3; BTC; HBEGF; ERRFI1;	GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway	8	35	22.8571428571429	0.00035208891040339	0.0117949784985136	1	1	0.626485160701855	0.999989987113883	0.106172802449129
down	LILRA5; TRIM16; ORM1; LPL; ORM2; LILRA2; TLR8; NLRP7;	GO:0050718~positive regulation of interleukin-1 beta secretion	8	35	22.8571428571429	0.00035208891040339	0.0117949784985136	1	1	0.626485160701855	0.999989987113883	0.106172802449129
up	S100A8; S100A9; S100A12;	GO:0050729~positive regulation of inflammatory response	3	78	3.84615384615385	0.00035700899626123	0.00666416793020967	0.0949643930054878	0.099962518953145	0.0813980511475609	0.0949643930054878	0.0414097395061434
down	CES2; PTGES; HPGD; AKR1C3; PTGR1; AKR1C1;	GO:0006693~prostaglandin metabolic process	6	18	33.3333333333333	0.00036506521817503	0.0119657347770176	1	1	0.633023088315504	0.999989987113883	0.107709869483786
down	ALOX15B; MT1E; MT1G; IGFBP5; MT1H; PTK6;	GO:0045926~negative regulation of growth	6	18	33.3333333333333	0.00036506521817503	0.0119657347770176	1	1	0.633023088315504	0.999989987113883	0.107709869483786
down	KCNQ1; ANK2; SCN5A; GPD1L; PKP2; KCNE1B;	GO:0086005~ventricular cardiac muscle cell action potential	6	18	33.3333333333333	0.00036506521817503	0.0119657347770176	1	1	0.633023088315504	0.999989987113883	0.107709869483786
down	JUP; DSP; DSC2; DLG1; PKP2;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	5	11	45.4545454545455	0.00037060610522199	0.01206058153851	1	1	0.63587845642453	0.999989987113883	0.108563635047847
up	S100A8; S100A9; SLC44A4;	GO:0030307~positive regulation of cell growth	3	82	3.65853658536585	0.0004112817295887	0.0071974302678024	0.108989658341008	0.115158884284838	0.091715825698282	0.108989658341008	0.0447233196438902
down	TULP3; WNT1; PLS3; GJA1; SRD5A1; STC1; SPNS2; SULF1; TTC9;	GO:0060348~bone development	9	46	19.5652173913043	0.00041707279353719	0.0134764797684786	1	1	0.658975013788774	0.999989987113883	0.121308879397166
down	NFASC; ERBB2; ERBB3; ALDH3A2; SOX8; PMP22; BDNF;	GO:0007422~peripheral nervous system development	7	27	25.9259259259259	0.00043023143745357	0.0135181684761275	1	1	0.664826627120117	0.999989987113883	0.121684141371754
down	F13A1; CSTA; ANXA1; KRT1; DSP; EVPL; TGM5;	GO:0018149~peptide cross-linking	7	27	25.9259259259259	0.00043023143745357	0.0135181684761275	1	1	0.664826627120117	0.999989987113883	0.121684141371754
down	TEAD1; YWHAE; TJP1; TEAD4; WWC1; WWTR1; TJP2;	GO:0035329~hippo signaling	7	27	25.9259259259259	0.00043023143745357	0.0135181684761275	1	1	0.664826627120117	0.999989987113883	0.121684141371754
down	RAMP2; ANXA1; HSPB1; MT1G; FLT4; KDR; DLL4;	GO:0035924~cellular response to vascular endothelial growth factor stimulus	7	27	25.9259259259259	0.00043023143745357	0.0135181684761275	1	1	0.664826627120117	0.999989987113883	0.121684141371754
down	MYO1B; MYO1E; MYH14; MYO6; WASL; WIPF3;	GO:0030048~actin filament-based movement	6	19	31.5789473684211	0.00046348758372849	0.0143649621188233	1	1	0.679618907227108	0.999989987113883	0.129306576135196
down	NRG2; N4BP3; TIMM8A; KALRN; OPHN1; PTN; BDNF; EFNA5; PCDH1; NAIP; LSAMP; GPM6B; ADGRV1; RAPGEF5; WNT8B; ATOH8; NDN; NRTN; CHRDL1; NRN1; RAPGEFL1; GNG8; IGSF9B; ERBB3; NTRK1; NTRK2; TYRO3;	GO:0007399~nervous system development	27	294	9.18367346938776	0.00048504336921428	0.0144761896155629	1	1	0.689161108985429	0.999989987113883	0.130307793309075
down	SPRY1; RARB; BMP4; BMP7; BDNF; SDC4; ARG2; NPNT;	GO:0001657~ureteric bud development	8	37	21.6216216216216	0.00048614069604502	0.0144761896155629	1	1	0.689545849584709	0.999989987113883	0.130307793309075
down	FZD6; DKK1; EGFR; DSG4; APCDD1; WNT10A; TNFRSF19; SOX21;	GO:0001942~hair follicle development	8	37	21.6216216216216	0.00048614069604502	0.0144761896155629	1	1	0.689545849584709	0.999989987113883	0.130307793309075
down	LILRA5; IFNG; LPL; AIF1; LILRA2; IL17RC; TRPV4; TLR8;	GO:2000778~positive regulation of interleukin-6 secretion	8	37	21.6216216216216	0.00048614069604502	0.0144761896155629	1	1	0.689545849584709	0.999989987113883	0.130307793309075
down	DSP; NECTIN1; GRHL1; PKP2;	GO:0002934~desmosome organization	4	6	66.6666666666667	0.00051478604191435	0.0151313884320115	1	1	0.69851095034127	0.999989987113883	0.136205582314155
down	JUP; DSP; DSC2; PKP2;	GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication	4	6	66.6666666666667	0.00051478604191435	0.0151313884320115	1	1	0.69851095034127	0.999989987113883	0.136205582314155
down	GJA1; RCVRN; OPRD1; RGS4; P2RX1; ANK2; P2RY12;	GO:0051924~regulation of calcium ion transport	7	28	25	0.00051857995950122	0.0151451942018433	1	1	0.699564365367145	0.999989987113883	0.136329855306531
up	S100A8; S100A9; S100A12; FCER1G;	GO:0042742~defense response to bacterium	4	216	1.85185185185185	0.00053976376959252	0.00889022679328868	0.142497635172427	0.151133855485908	0.113350391614431	0.142497635172427	0.0552420016296076
down	FOXP2; CKB; PTN; FCGR2B; SSTR3; AIF1; CNTN1; SCN5A; PPARGC1A;	GO:0021549~cerebellum development	9	48	18.75	0.00054770648933588	0.0158939539198363	1	1	0.707636784221965	0.999989987113883	0.143069835174265
down	RAMP2; DLG1; GRHL2; MARVELD2; PATJ; PARD3; MARVELD3; CRB3;	GO:0070830~bicellular tight junction assembly	8	38	21.0526315789474	0.00056718545634093	0.0163550439182867	1	1	0.712384933164214	0.999989987113883	0.147220348659551
down	NRG2; EREG; EGFR; ERBB2; ERBB3; BTC; HBEGF;	GO:2000145~regulation of cell motility	7	29	24.1379310344828	0.00062077647953584	0.0175605319516976	1	1	0.725647139116762	0.999989987113883	0.158071580210524
down	WNT10B; BMP4; BMP7; PTN; WNT4; GPM6B; TMEM119; ADGRV1;	GO:0030501~positive regulation of bone mineralization	8	39	20.5128205128205	0.00065880514915905	0.0183019284120041	1	1	0.734301973604899	0.999989987113883	0.16474527952473
down	GNA15; GPR157; LPAR3; GPR65; P2RY10; F2RL3; GPR174; GPR55;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	8	39	20.5128205128205	0.00065880514915905	0.0183019284120041	1	1	0.734301973604899	0.999989987113883	0.16474527952473
down	EREG; EGFR; TGFA; VIL1; BTC; GRB7; FAM83B; HBEGF; GAREM1;	GO:0007173~epidermal growth factor receptor signaling pathway	9	50	18	0.0007100809838334	0.0195893108356452	1	1	0.745518189289167	0.999989987113883	0.176333685536573
down	FOXE1; KLF4; AIRE; TRIM16; EGFR; TF; WNT1; BMP4; CDH1; GATA1; TAL1; SPI1; BMP7; CCNA2; CCNE1; TEAD1; CD80; PPARG; SOX2; WNT4; SOX8; ACTA2; ELF3; POU3F1; MECOM; PPARD; FOXM1; IRF4; CASZ1; SKAP1; TP53INP2; MYOCD; SETD7; ARNTL2; ATOH8; NPAS2; SOX7; ARNT2; GCM1; EHF; PPARGC1A; HEY2; TBX21;	GO:0045893~positive regulation of transcription, DNA-templated	43	570	7.54385964912281	0.00071408523783123	0.0195893108356452	1	1	0.746265937001451	0.999989987113883	0.176333685536573
down	KIT; BMP4; SPI1; BATF;	GO:0002320~lymphoid progenitor cell differentiation	4	7	57.1428571428571	0.00078227233038674	0.0207378709002927	1	1	0.761150977466304	0.999989987113883	0.186672478511918
down	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.00078227233038674	0.0207378709002927	1	1	0.761150977466304	0.999989987113883	0.186672478511918
down	KIF4A; KIF23; AURKB; RACGAP1;	GO:0051256~mitotic spindle midzone assembly	4	7	57.1428571428571	0.00078227233038674	0.0207378709002927	1	1	0.761150977466304	0.999989987113883	0.186672478511918
down	CCNE1; CCNB1; CCNA2; CCNO; CCNA1; CCNB2;	GO:0044772~mitotic cell cycle phase transition	6	22	27.2727272727273	0.0008859061233738	0.0228772717179213	1	1	0.783808029038908	0.999989987113883	0.205930350020391
down	DLG2; DLG3; PARD3; LRRC1; PARD3B; DLG1;	GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity	6	22	27.2727272727273	0.0008859061233738	0.0228772717179213	1	1	0.783808029038908	0.999989987113883	0.205930350020391
down	SCNN1A; SCNN1B; SCN7A; SLC12A3; SLC12A1;	GO:0055078~sodium ion homeostasis	5	14	35.7142857142857	0.00088877899343109	0.0228772717179213	1	1	0.784388701568811	0.999989987113883	0.205930350020391
down	WNT10B; WNT1; MECOM; WNT2B; SFRP2;	GO:0071425~hematopoietic stem cell proliferation	5	14	35.7142857142857	0.00088877899343109	0.0228772717179213	1	1	0.784388701568811	0.999989987113883	0.205930350020391
down	NCR1; KLRC2; MNDA; CCR2; CCR5; KLRC3; TRAT1; LILRB2; IL1RL2;	GO:0006968~cellular defense response	9	53	16.9811320754717	0.00102533252209791	0.0260972903389837	1	1	0.809616866837945	0.999989987113883	0.234915430491684
down	CDC45; CCNE1; RRM2; CCNA1; CDC6; CDT1;	GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle	6	23	26.0869565217391	0.00107793993026273	0.0268365809960491	1	1	0.818574972102651	0.999989987113883	0.241570174363831
down	TLCD2; SPTA1; BAIAP2L2; TLCD1; A4GALT; BAIAP2;	GO:0007009~plasma membrane organization	6	23	26.0869565217391	0.00107793993026273	0.0268365809960491	1	1	0.818574972102651	0.999989987113883	0.241570174363831
down	GREM1; EPHA3; EFNA5; GPM6B; CAMSAP3; LIMCH1;	GO:0051893~regulation of focal adhesion assembly	6	23	26.0869565217391	0.00107793993026273	0.0268365809960491	1	1	0.818574972102651	0.999989987113883	0.241570174363831
down	UNC13B; GIPC1; SNCG; DBH; SLC6A1; SLC1A3; SLC1A1; HTR3A; PMP22; RAPSN; GRIK4; SYPL1; LPAR3; GABRP; GABRQ; HRH2; CHRFAM7A; GABRE; DLG1; CHRNB4; CACNB2; DLG2; CHRNG;	GO:0007268~chemical synaptic transmission	23	249	9.23694779116466	0.00113445336782447	0.0271827182020421	1	1	0.82808529162736	0.999989987113883	0.24468593732998
down	CEACAM1; PTN; EMP2; RHOJ;	GO:0010594~regulation of endothelial cell migration	4	8	50	0.00113477032095988	0.0271827182020421	1	1	0.82808529162736	0.999989987113883	0.24468593732998
down	DBH; MAOA; MAOB; MOXD1;	GO:0042420~dopamine catabolic process	4	8	50	0.00113477032095988	0.0271827182020421	1	1	0.82808529162736	0.999989987113883	0.24468593732998
down	TOM1L1; BMP4; BMP7; TOM1L2;	GO:0045839~negative regulation of mitotic nuclear division	4	8	50	0.00113477032095988	0.0271827182020421	1	1	0.82808529162736	0.999989987113883	0.24468593732998
down	DLG1; DLG2; MAGI3; TJP2;	GO:0046710~GDP metabolic process	4	8	50	0.00113477032095988	0.0271827182020421	1	1	0.82808529162736	0.999989987113883	0.24468593732998
down	DKK1; C1QA; C1QC; CX3CL1;	GO:0098883~synapse pruning	4	8	50	0.00113477032095988	0.0271827182020421	1	1	0.82808529162736	0.999989987113883	0.24468593732998
down	COBL; FAM98A; EPS8L1; P2RY12; EPS8L2;	GO:1900029~positive regulation of ruffle assembly	5	15	33.3333333333333	0.00114459865172911	0.0271827182020421	1	1	0.829769587929589	0.999989987113883	0.24468593732998
down	MT-CYB; WNT1; CDK1; GSTP1; ANXA3; CCNA2; FLT3; PPARG;	GO:0031100~animal organ regeneration	8	43	18.6046511627907	0.00115150671927	0.0271827182020421	1	1	0.830794706398428	0.999989987113883	0.24468593732998
down	EGFR; ERBB2; GSTP1; VIL1; SKAP1; GAREM1; ERRFI1; BAIAP2;	GO:0071364~cellular response to epidermal growth factor stimulus	8	43	18.6046511627907	0.00115150671927	0.0271827182020421	1	1	0.830794706398428	0.999989987113883	0.24468593732998
down	ERBB2; ERBB3; LTK; TYRO3; NYAP1; PIK3R5; PIK3C2G;	GO:0014065~phosphatidylinositol 3-kinase signaling	7	33	21.2121212121212	0.00119915237892942	0.0277326814132104	1	1	0.838207512871668	0.999989987113883	0.249636445326329
down	CCL26; CX3CL1; XCL2; CCL20; CCL24; CCL21; CCL17;	GO:0048247~lymphocyte chemotaxis	7	33	21.2121212121212	0.00119915237892942	0.0277326814132104	1	1	0.838207512871668	0.999989987113883	0.249636445326329
down	PF4; CXCR5; CNR2; CX3CL1; SBDS; CXCL6;	GO:0030595~leukocyte chemotaxis	6	24	25	0.00130033535056506	0.029742850742709	1	1	0.849552324447563	0.999989987113883	0.267731036269165
down	SLC7A2; SLC7A3; SLC7A1;	GO:0097638~L-arginine import across plasma membrane	3	3	100	0.0013121845915901	0.029742850742709	1	1	0.850721433150931	0.999989987113883	0.267731036269165
down	SLC7A1; SLC7A3; SLC7A2;	GO:1903352~L-ornithine transmembrane transport	3	3	100	0.0013121845915901	0.029742850742709	1	1	0.850721433150931	0.999989987113883	0.267731036269165
down	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0013121845915901	0.029742850742709	1	1	0.850721433150931	0.999989987113883	0.267731036269165
down	SCD; SC5D; TM7SF2; FDPS; HMGCS1; SQLE; ELOVL6;	GO:0045540~regulation of cholesterol biosynthetic process	7	34	20.5882352941176	0.00139460978773565	0.0309943521606029	1	1	0.859004692687561	0.999989987113883	0.278996458484526
down	FOXP2; BMP4; EDN2; IGFBP5; FLT4; MYOCD; ERRFI1;	GO:0048286~lung alveolus development	7	34	20.5882352941176	0.00139460978773565	0.0309943521606029	1	1	0.859004692687561	0.999989987113883	0.278996458484526
down	KLF4; GREM1; NEK2; GRHL2; PARM1; AURKB; PKIB;	GO:0051973~positive regulation of telomerase activity	7	34	20.5882352941176	0.00139460978773565	0.0309943521606029	1	1	0.859004692687561	0.999989987113883	0.278996458484526
down	E2F8; AURKA; CDK1; CCNB1; MUC1; CDC25C; SFN; TNKS1BP1; GTSE1;	GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	9	56	16.0714285714286	0.00144532691207977	0.0311844818048657	1	1	0.863984608240645	0.999989987113883	0.280707915369553
down	AURKA; TTK; AURKB; SPAG5; AUNIP;	GO:0007051~spindle organization	5	16	31.25	0.00145107773104292	0.0311844818048657	1	1	0.864560198748346	0.999989987113883	0.280707915369553
down	SQLE; CYB5R2; CYB5R1; SC5D; TM7SF2;	GO:0016126~sterol biosynthetic process	5	16	31.25	0.00145107773104292	0.0311844818048657	1	1	0.864560198748346	0.999989987113883	0.280707915369553
down	CTLA4; FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	5	16	31.25	0.00145107773104292	0.0311844818048657	1	1	0.864560198748346	0.999989987113883	0.280707915369553
down	MT-CYB; CYB5A; CDK1; KIT; GOT1; HAAO;	GO:0046686~response to cadmium ion	6	25	24	0.00155611629114905	0.0326799461976249	1	1	0.872611031932513	0.999989987113883	0.294169376580537
down	GRHL2; HEYL; DLL4; HEY2;	GO:0003208~cardiac ventricle morphogenesis	4	9	44.4444444444444	0.00158522127078031	0.0326799461976249	1	1	0.874846183544438	0.999989987113883	0.294169376580537
down	MATN2; CD9; P2RY1; NDN;	GO:0008347~glial cell migration	4	9	44.4444444444444	0.00158522127078031	0.0326799461976249	1	1	0.874846183544438	0.999989987113883	0.294169376580537
down	SASH1; LY86; SCIMP; CD180;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	4	9	44.4444444444444	0.00158522127078031	0.0326799461976249	1	1	0.874846183544438	0.999989987113883	0.294169376580537
down	BUB1; MKI67; AURKB; KIF2C;	GO:0051983~regulation of chromosome segregation	4	9	44.4444444444444	0.00158522127078031	0.0326799461976249	1	1	0.874846183544438	0.999989987113883	0.294169376580537
down	GJA1; KCNQ1; ANK2; SCN5A;	GO:0086014~atrial cardiac muscle cell action potential	4	9	44.4444444444444	0.00158522127078031	0.0326799461976249	1	1	0.874846183544438	0.999989987113883	0.294169376580537
down	EDN2; NMU; PRKAA2; IRX3; PM20D1; TRPV4; PPARGC1A;	GO:0097009~energy homeostasis	7	35	20	0.00161405844832774	0.0329760102716645	1	1	0.876905155114776	0.999989987113883	0.296834404960983
down	PRL; NGFR; SPI1; TEAD1; KLF5; ATOH8; GNL3;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	7	35	20	0.00161405844832774	0.0329760102716645	1	1	0.876905155114776	0.999989987113883	0.296834404960983
down	KIT; BMP4; GATA1; TAL1; SPI1; EPAS1; TRIM10; C15orf41;	GO:0030218~erythrocyte differentiation	8	46	17.3913043478261	0.00168535864641828	0.0341266399692519	1	1	0.881177934184761	0.999989987113883	0.30719182779049
down	CCL21; TRPM2; CXCR1; CCR2; CCR5;	GO:0002407~dendritic cell chemotaxis	5	17	29.4117647058824	0.001813928306861	0.0365675104692864	1	1	0.88835214545426	0.999989987113883	0.32916338640221
down	DKK1; RNF43; SOSTDC1; APCDD1; FRZB; SFRP2; BARX1; CTNNBIP1;	GO:0030178~negative regulation of Wnt signaling pathway	8	47	17.0212765957447	0.00190123708940904	0.0379913867515244	1	1	0.893256781177955	0.999989987113883	0.341980445394315
down	EREG; VEGFD; TGFA; OSM; TAL1; PTN; BTC; GAREM1;	GO:0051781~positive regulation of cell division	8	47	17.0212765957447	0.00190123708940904	0.0379913867515244	1	1	0.893256781177955	0.999989987113883	0.341980445394315
down	FFAR3; ADCY5; ADRA2A; NPR3; OPRD1; P2RY1; GNAI1; RXFP2; P2RY12;	GO:0007193~adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	9	59	15.2542372881356	0.00199356668446038	0.0391495250620754	1	1	0.898376227529548	0.999989987113883	0.352405457196617
down	DKK1; EGFR; S100B; NTRK1; GM2A; CRHBP; GLP1R; GATM; LILRB2;	GO:0007611~learning or memory	9	59	15.2542372881356	0.00199356668446038	0.0391495250620754	1	1	0.898376227529548	0.999989987113883	0.352405457196617
down	EREG; EGFR; WNT1; NGFR; CCNB1; CCNA2; BTC; CDC6;	GO:0048146~positive regulation of fibroblast proliferation	8	48	16.6666666666667	0.00213831916061447	0.0395378281878151	1	1	0.90520554785216	0.999989987113883	0.35590077777433
down	GCAT; ALDH1L1; ALDH1L2; KYAT3;	GO:0009058~biosynthetic process	4	10	40	0.00214645360758037	0.0395378281878151	1	1	0.905665031676529	0.999989987113883	0.35590077777433
down	EMP1; EMP2; PMP22; LPAR3;	GO:0032060~bleb assembly	4	10	40	0.00214645360758037	0.0395378281878151	1	1	0.905665031676529	0.999989987113883	0.35590077777433
down	GOT1; PPARG; PPARD; ERRFI1;	GO:0032966~negative regulation of collagen biosynthetic process	4	10	40	0.00214645360758037	0.0395378281878151	1	1	0.905665031676529	0.999989987113883	0.35590077777433
down	LGALS3; IL27; CD209; TNFSF18;	GO:0042129~regulation of T cell proliferation	4	10	40	0.00214645360758037	0.0395378281878151	1	1	0.905665031676529	0.999989987113883	0.35590077777433
down	DLG1; DLG2; MAGI3; TJP2;	GO:0046037~GMP metabolic process	4	10	40	0.00214645360758037	0.0395378281878151	1	1	0.905665031676529	0.999989987113883	0.35590077777433
down	HSPB1; MET; LGMN; SMOC2;	GO:2001028~positive regulation of endothelial cell chemotaxis	4	10	40	0.00214645360758037	0.0395378281878151	1	1	0.905665031676529	0.999989987113883	0.35590077777433
down	IFNG; C1QA; AIF1; CX3CL1; TLR8; TLR7;	GO:0001774~microglial cell activation	6	27	22.2222222222222	0.00218042839482413	0.0395378281878151	1	1	0.907058212246838	0.999989987113883	0.35590077777433
down	CCL21; JUP; EPHA1; EMP2; CX3CL1; SKAP1;	GO:0001954~positive regulation of cell-matrix adhesion	6	27	22.2222222222222	0.00218042839482413	0.0395378281878151	1	1	0.907058212246838	0.999989987113883	0.35590077777433
down	ALOX15B; ALOX12; PLA2G4A; FAAH2; MGLL; CYP4F11;	GO:0019369~arachidonic acid metabolic process	6	27	22.2222222222222	0.00218042839482413	0.0395378281878151	1	1	0.907058212246838	0.999989987113883	0.35590077777433
down	BMP4; CDH1; SRD5A1; MSX1; SOX2; PITX1;	GO:0021983~pituitary gland development	6	27	22.2222222222222	0.00218042839482413	0.0395378281878151	1	1	0.907058212246838	0.999989987113883	0.35590077777433
down	PPARG; THRB; RARG; PCK2; PPARD; RARB;	GO:0033993~response to lipid	6	27	22.2222222222222	0.00218042839482413	0.0395378281878151	1	1	0.907058212246838	0.999989987113883	0.35590077777433
down	WNT10B; BMP4; BMP7; WNT4; TMEM119; FFAR4; NPNT; SFRP2; CTNNBIP1;	GO:0045669~positive regulation of osteoblast differentiation	9	60	15	0.00220924520357368	0.0395378281878151	1	1	0.908036760850833	0.999989987113883	0.35590077777433
down	WWC1; REEP6; REEP1;	GO:0032386~regulation of intracellular transport	3	4	75	0.00222514293827514	0.0395378281878151	1	1	0.908773414776439	0.999989987113883	0.35590077777433
down	MSX1; PAX9; SP6;	GO:0042481~regulation of odontogenesis	3	4	75	0.00222514293827514	0.0395378281878151	1	1	0.908773414776439	0.999989987113883	0.35590077777433
down	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.00222514293827514	0.0395378281878151	1	1	0.908773414776439	0.999989987113883	0.35590077777433
down	TAL1; SOX8; GCM1;	GO:0060018~astrocyte fate commitment	3	4	75	0.00222514293827514	0.0395378281878151	1	1	0.908773414776439	0.999989987113883	0.35590077777433
down	BMP4; BMP7; SULF1;	GO:0060686~negative regulation of prostatic bud formation	3	4	75	0.00222514293827514	0.0395378281878151	1	1	0.908773414776439	0.999989987113883	0.35590077777433
down	DLG1; DLG2; DLG3;	GO:0099562~maintenance of postsynaptic density structure	3	4	75	0.00222514293827514	0.0395378281878151	1	1	0.908773414776439	0.999989987113883	0.35590077777433
down	ANXA8; ANXA1; ANXA8L1;	GO:1900138~negative regulation of phospholipase A2 activity	3	4	75	0.00222514293827514	0.0395378281878151	1	1	0.908773414776439	0.999989987113883	0.35590077777433
down	TJP1; ANGPT1; TJP2;	GO:1905605~positive regulation of maintenance of permeability of blood-brain barrier	3	4	75	0.00222514293827514	0.0395378281878151	1	1	0.908773414776439	0.999989987113883	0.35590077777433
down	FUT3; SOX2; FUT7; MAGI1; SIRPG;	GO:0022409~positive regulation of cell-cell adhesion	5	18	27.7777777777778	0.00223897271125029	0.0395378281878151	1	1	0.909271226445656	0.999989987113883	0.35590077777433
down	TUBB4B; PRDX1; IL18; RAET1E; ULBP2;	GO:0042267~natural killer cell mediated cytotoxicity	5	18	27.7777777777778	0.00223897271125029	0.0395378281878151	1	1	0.909271226445656	0.999989987113883	0.35590077777433
down	EDN2; NPNT; MYOCD; PROK2; NMU;	GO:0045987~positive regulation of smooth muscle contraction	5	18	27.7777777777778	0.00223897271125029	0.0395378281878151	1	1	0.909271226445656	0.999989987113883	0.35590077777433
down	CCR2; AIF1; CXCL17; LGMN; S100A14;	GO:0090026~positive regulation of monocyte chemotaxis	5	18	27.7777777777778	0.00223897271125029	0.0395378281878151	1	1	0.909271226445656	0.999989987113883	0.35590077777433
down	CIT; GIPC1; CXCR5; KIF23; AURKB; CDC6; RACGAP1;	GO:0032467~positive regulation of cytokinesis	7	38	18.4210526315789	0.00243608935330553	0.0423619202048091	1	1	0.917449561011352	0.999989987113883	0.381321914731574
down	GPX3; HBA1; PRDX1; DUOX1; HBZ; HBD;	GO:0042744~hydrogen peroxide catabolic process	6	28	21.4285714285714	0.0025554706000086	0.0437696392993955	1	1	0.922438345096427	0.999989987113883	0.393993534383295
down	COBL; KIT; CCNB1; HRH2; MYOCD; MIXL1;	GO:0048565~digestive tract development	6	28	21.4285714285714	0.0025554706000086	0.0437696392993955	1	1	0.922438345096427	0.999989987113883	0.393993534383295
down	LRRC8A; TRPV4; SLC12A3; SLC12A8; SLC12A1;	GO:0006884~cell volume homeostasis	5	19	26.3157894736842	0.00273210626209197	0.0464458064555635	1	1	0.929422642815532	0.999989987113883	0.418083121899583
down	EGFR; FMO1; MAP7; LRRC8A; MARVELD3;	GO:0006970~response to osmotic stress	5	19	26.3157894736842	0.00273210626209197	0.0464458064555635	1	1	0.929422642815532	0.999989987113883	0.418083121899583
down	EFNA5; EPHB3; WNT4; FUT7;	GO:0022407~regulation of cell-cell adhesion	4	11	36.3636363636364	0.00283104205381834	0.047073823347432	1	1	0.933676055959347	0.999989987113883	0.423736232111142
down	FUT3; FUT2; FUT7; FUT6;	GO:0036065~fucosylation	4	11	36.3636363636364	0.00283104205381834	0.047073823347432	1	1	0.933676055959347	0.999989987113883	0.423736232111142
down	EREG; FST; PPARD; SDR16C5;	GO:0043616~keratinocyte proliferation	4	11	36.3636363636364	0.00283104205381834	0.047073823347432	1	1	0.933676055959347	0.999989987113883	0.423736232111142
down	VIL1; LMOD1; SPIRE1; SCIN;	GO:0045010~actin nucleation	4	11	36.3636363636364	0.00283104205381834	0.047073823347432	1	1	0.933676055959347	0.999989987113883	0.423736232111142
down	CTNND1; YWHAE; CPT1C; DLG3;	GO:0099072~regulation of postsynaptic membrane neurotransmitter receptor levels	4	11	36.3636363636364	0.00283104205381834	0.047073823347432	1	1	0.933676055959347	0.999989987113883	0.423736232111142
up	TSPAN8; CRNN; POGZ;	GO:0010468~regulation of gene expression	3	166	1.80722891566265	0.00297182316082278	0.0320169198809347	0.766730375492278	0.83211048503038	0.303941490708564	0.618845478388709	0.198946414007436
down	WASL; COBL; VIL1; AIF1; SPIRE1; DIAPH3;	GO:0030041~actin filament polymerization	6	29	20.6896551724138	0.00297689624975139	0.048786832064271	1	1	0.939581621316049	0.999989987113883	0.439155924152929
down	NCKAP1L; DLG1; EPB41L1; CIT; LLGL2; NCKAP1;	GO:0030866~cortical actin cytoskeleton organization	6	29	20.6896551724138	0.00297689624975139	0.048786832064271	1	1	0.939581621316049	0.999989987113883	0.439155924152929
down	ORM1; BPI; NCKAP1L; CX3CL1; SLAMF1; TLR9;	GO:0032715~negative regulation of interleukin-6 production	6	29	20.6896551724138	0.00297689624975139	0.048786832064271	1	1	0.939581621316049	0.999989987113883	0.439155924152929
down	TM7SF2; FDPS; PRKAA2; HMGCS1; SQLE; DHCR24; NPC1L1;	GO:0006695~cholesterol biosynthetic process	7	40	17.5	0.00314126112876023	0.050930909973778	1	1	0.946120733914082	0.999989987113883	0.458455896624292
down	CCNB1; RAB11A; CEP55; CDCA8; CDCA5; KIF2C; KIFC1;	GO:0007080~mitotic metaphase plate congression	7	40	17.5	0.00314126112876023	0.050930909973778	1	1	0.946120733914082	0.999989987113883	0.458455896624292
down	PRLR; FBLN1; STC1; EMP2; FKBP4; PPARD; FUT7;	GO:0007566~embryo implantation	7	40	17.5	0.00314126112876023	0.050930909973778	1	1	0.946120733914082	0.999989987113883	0.458455896624292
down	VEGFD; FLT4; KDR; NCKAP1L; SHC2; SHB; SULF1; BAIAP2; NCKAP1;	GO:0048010~vascular endothelial growth factor receptor signaling pathway	9	64	14.0625	0.00326412236531437	0.0524550773651708	1	1	0.951238138479988	0.999989987113883	0.472175728616028
down	NEFH; NCKAP1L; NCKAP1; RHOJ; PARVG;	GO:0030031~cell projection assembly	5	20	25	0.00329926093172983	0.0524550773651708	1	1	0.952853835163497	0.999989987113883	0.472175728616028
down	NTRK1; NGFR; BDNF; NTRK2; NDN;	GO:0048011~neurotrophin TRK receptor signaling pathway	5	20	25	0.00329926093172983	0.0524550773651708	1	1	0.952853835163497	0.999989987113883	0.472175728616028
down	CCL21; CLDN7; NTN1; TF; DUOX1;	GO:2000147~positive regulation of cell motility	5	20	25	0.00329926093172983	0.0524550773651708	1	1	0.952853835163497	0.999989987113883	0.472175728616028
down	NR2F6; RARB; THRB; BMP4; RARG; BMP7; PPARG; PPARD;	GO:0043401~steroid hormone mediated signaling pathway	8	52	15.3846153846154	0.00332737431047725	0.0524550773651708	1	1	0.953952859194828	0.999989987113883	0.472175728616028
down	ZBTB7C; LPL; PPARG; PPARD; KLF5; FRZB; SFRP2; CCDC3;	GO:0045600~positive regulation of fat cell differentiation	8	52	15.3846153846154	0.00332737431047725	0.0524550773651708	1	1	0.953952859194828	0.999989987113883	0.472175728616028
down	ADGRV1; GABRQ; HTR3A; CHRNB4; GABRP; GABRE; CHRFAM7A; CHRNG;	GO:0050877~nervous system process	8	52	15.3846153846154	0.00332737431047725	0.0524550773651708	1	1	0.953952859194828	0.999989987113883	0.472175728616028
down	ATP8B1; CEACAM1; AKR1C1; STARD5; SLCO2B1; SLC10A6;	GO:0015721~bile acid and bile salt transport	6	30	20	0.00344812020378948	0.0525709514918416	1	1	0.958577416653477	0.999989987113883	0.473218772548795
down	OIP5; CENPA; CENPU; HJURP; CENPI; CENPN;	GO:0034080~CENP-A containing nucleosome assembly	6	30	20	0.00344812020378948	0.0525709514918416	1	1	0.958577416653477	0.999989987113883	0.473218772548795
down	EGFR; DBH; GJA1; HRH2; AVPR2; AVPR1A;	GO:0045907~positive regulation of vasoconstriction	6	30	20	0.00344812020378948	0.0525709514918416	1	1	0.958577416653477	0.999989987113883	0.473218772548795
down	KIF23; RACGAP1; ANLN;	GO:0000915~actomyosin contractile ring assembly	3	5	60	0.00345011292714237	0.0525709514918416	1	1	0.9591280103297	0.999989987113883	0.473218772548795
down	TRPM2; SLC6A1; HMGCS1;	GO:0014074~response to purine-containing compound	3	5	60	0.00345011292714237	0.0525709514918416	1	1	0.9591280103297	0.999989987113883	0.473218772548795
down	ATP8B1; PLD1; KLF5;	GO:0032534~regulation of microvillus assembly	3	5	60	0.00345011292714237	0.0525709514918416	1	1	0.9591280103297	0.999989987113883	0.473218772548795
down	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.00345011292714237	0.0525709514918416	1	1	0.9591280103297	0.999989987113883	0.473218772548795
down	P2RY1; P2RX1; P2RY12;	GO:0043270~positive regulation of ion transport	3	5	60	0.00345011292714237	0.0525709514918416	1	1	0.9591280103297	0.999989987113883	0.473218772548795
down	ALOX12; PPARG; PPARD;	GO:0071396~cellular response to lipid	3	5	60	0.00345011292714237	0.0525709514918416	1	1	0.9591280103297	0.999989987113883	0.473218772548795
down	PRC1; KIF20A; PLK1; RAB11A; MYO19; AURKA; AURKB;	GO:0032465~regulation of cytokinesis	7	41	17.0731707317073	0.00354747891662432	0.0538743798138014	1	1	0.962802143602943	0.999989987113883	0.484951616127228
down	CCL24; CLDN4; EGFR; F10; ADRA2A; VIL1; EPHA1; KDR; CEACAM6; AIF1; TJP1; GRB7; FAM110C; SH3RF2; CEMIP; HBEGF; GTSE1; CCL26; KIT; SEMA3A;	GO:0030335~positive regulation of cell migration	20	226	8.84955752212389	0.0035987169742967	0.0543621230649044	1	1	0.964711726027852	0.999989987113883	0.489342049552077
down	CCNB2; CDK1; CCNB1; PLK1;	GO:0007077~mitotic nuclear envelope disassembly	4	12	33.3333333333333	0.00365118737003089	0.0543621230649044	1	1	0.967337401862102	0.999989987113883	0.489342049552077
down	TULP3; RARG; NES; RDH10;	GO:0031076~embryonic camera-type eye development	4	12	33.3333333333333	0.00365118737003089	0.0543621230649044	1	1	0.967337401862102	0.999989987113883	0.489342049552077
down	HPN; MET; MST1R; MUC20;	GO:0048012~hepatocyte growth factor receptor signaling pathway	4	12	33.3333333333333	0.00365118737003089	0.0543621230649044	1	1	0.967337401862102	0.999989987113883	0.489342049552077
down	IL2RA; CTLA4; FCGR2B; SPINK5;	GO:0050777~negative regulation of immune response	4	12	33.3333333333333	0.00365118737003089	0.0543621230649044	1	1	0.967337401862102	0.999989987113883	0.489342049552077
down	TRPM2; GATA1; FLT3; LILRB1;	GO:0097028~dendritic cell differentiation	4	12	33.3333333333333	0.00365118737003089	0.0543621230649044	1	1	0.967337401862102	0.999989987113883	0.489342049552077
down	CNR2; CCR2; BDKRB1; P2RY1; NMU; DLG2; NDN; PROK2;	GO:0019233~sensory perception of pain	8	53	15.0943396226415	0.00369230704721868	0.0544406178224217	1	1	0.968685721885095	0.999989987113883	0.490048622131605
down	SPTA1; KIT; TAL1; FLT3; CCR2; MELK; ANGPT1; MECOM;	GO:0030097~hemopoiesis	8	53	15.0943396226415	0.00369230704721868	0.0544406178224217	1	1	0.968685721885095	0.999989987113883	0.490048622131605
down	MMP8; SCIMP; LILRB2; IL1RL2; TLR9; IL36A; TLR8; TLR7;	GO:0032755~positive regulation of interleukin-6 production	8	53	15.0943396226415	0.00369230704721868	0.0544406178224217	1	1	0.968685721885095	0.999989987113883	0.490048622131605
down	SPRY1; GJA1; CENPA; PLK1; GPSM2; SAPCD2;	GO:0000132~establishment of mitotic spindle orientation	6	31	19.3548387096774	0.00397259844125153	0.0571997426045756	1	1	0.977682808406579	0.999989987113883	0.514884954852774
down	IRX5; ANK2; SCN5A; SEMA3A; GPD1L; EPAS1;	GO:0002027~regulation of heart rate	6	31	19.3548387096774	0.00397259844125153	0.0571997426045756	1	1	0.977682808406579	0.999989987113883	0.514884954852774
down	BUB1; BUB1B; ZWINT; CDKN2B; DLG1; TICRR;	GO:0007093~mitotic cell cycle checkpoint	6	31	19.3548387096774	0.00397259844125153	0.0571997426045756	1	1	0.977682808406579	0.999989987113883	0.514884954852774
down	JCHAIN; IGKV3-20; IGHA2; SEMG1; DEFB1; RNASE6;	GO:0019731~antibacterial humoral response	6	31	19.3548387096774	0.00397259844125153	0.0571997426045756	1	1	0.977682808406579	0.999989987113883	0.514884954852774
down	CCL21; KIT; CD19; FGFR3; FLT3; P2RY12;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	6	31	19.3548387096774	0.00397259844125153	0.0571997426045756	1	1	0.977682808406579	0.999989987113883	0.514884954852774
down	SPTLC1; P2RX1; CYP4F22; SPTSSB; CERS4; DEGS2;	GO:0046513~ceramide biosynthetic process	6	31	19.3548387096774	0.00397259844125153	0.0571997426045756	1	1	0.977682808406579	0.999989987113883	0.514884954852774
down	NEK2; RAB11A; CDC20; KIFC1; TPX2; BIRC5;	GO:0090307~mitotic spindle assembly	6	31	19.3548387096774	0.00397259844125153	0.0571997426045756	1	1	0.977682808406579	0.999989987113883	0.514884954852774
down	WNT1; BMP4; WNT4; DLG1; NPNT; EYA1; CTNNBIP1;	GO:0001658~branching involved in ureteric bud morphogenesis	7	42	16.6666666666667	0.00399243155141682	0.0571997426045756	1	1	0.978145730097121	0.999989987113883	0.514884954852774
down	SLC26A4; CA4; CA6; HBA1; CYB5R2; CA13; CYB5R1;	GO:0015701~bicarbonate transport	7	42	16.6666666666667	0.00399243155141682	0.0571997426045756	1	1	0.978145730097121	0.999989987113883	0.514884954852774
down	SASH1; ANXA3; BMP4; FLT4; KDR; ANGPT1; ATOH8; SMOC2;	GO:0010595~positive regulation of endothelial cell migration	8	54	14.8148148148148	0.00408741438443816	0.0581945622984383	1	1	0.98047898922771	0.999989987113883	0.523839849924631
up	S100A8; S100A9; S100A12; CXCL11;	GO:0006954~inflammatory response	4	381	1.0498687664042	0.00415022290222755	0.0320169198809347	1	1	0.356919169591569	0.618845478388709	0.198946414007436
down	LIM2; TJP1; TRPV4; CDH1; PKP2; CTNND1; CDH26;	GO:0007043~cell-cell junction assembly	7	43	16.2790697674419	0.00447839545107054	0.0626262165925783	1	1	0.986697760576159	0.999989987113883	0.56373150008354
down	RAMP2; TULP3; RGS20; RGS11; RGS4; GNG4; HOMER2;	GO:0008277~regulation of G protein-coupled receptor signaling pathway	7	43	16.2790697674419	0.00447839545107054	0.0626262165925783	1	1	0.986697760576159	0.999989987113883	0.56373150008354
down	E2F8; RAMP2; FLT4; ANGPT1; KDR; VEGFD;	GO:0002040~sprouting angiogenesis	6	32	18.75	0.00455381533176535	0.0626262165925783	1	1	0.988119355242575	0.999989987113883	0.56373150008354
down	TSPAN12; KRT1; ERBB2; EPHA2; EMP2; PROK2;	GO:0045765~regulation of angiogenesis	6	32	18.75	0.00455381533176535	0.0626262165925783	1	1	0.988119355242575	0.999989987113883	0.56373150008354
down	TPPP; EPHA3; EFNA5; PRKAA2; PHLDB2; CAMSAP3;	GO:0070507~regulation of microtubule cytoskeleton organization	6	32	18.75	0.00455381533176535	0.0626262165925783	1	1	0.988119355242575	0.999989987113883	0.56373150008354
down	BMP4; MSX1; HEYL; HEY2;	GO:0003198~epithelial to mesenchymal transition involved in endocardial cushion formation	4	13	30.7692307692308	0.00461861474431657	0.0626262165925783	1	1	0.988851583651156	0.999989987113883	0.56373150008354
down	GREM1; PRLR; EFNA5; ANGPT1;	GO:0007171~activation of transmembrane receptor protein tyrosine kinase activity	4	13	30.7692307692308	0.00461861474431657	0.0626262165925783	1	1	0.988851583651156	0.999989987113883	0.56373150008354
down	CCL21; KIT; CDC42EP1; C15orf62;	GO:0031274~positive regulation of pseudopodium assembly	4	13	30.7692307692308	0.00461861474431657	0.0626262165925783	1	1	0.988851583651156	0.999989987113883	0.56373150008354
down	FLT4; KDR; FLT3; VEGFD;	GO:0038084~vascular endothelial growth factor signaling pathway	4	13	30.7692307692308	0.00461861474431657	0.0626262165925783	1	1	0.988851583651156	0.999989987113883	0.56373150008354
down	ELOVL7; HACD2; TECR; ELOVL6;	GO:0042761~very long-chain fatty acid biosynthetic process	4	13	30.7692307692308	0.00461861474431657	0.0626262165925783	1	1	0.988851583651156	0.999989987113883	0.56373150008354
down	HPN; KIT; ADGRV1; TMC1;	GO:0050910~detection of mechanical stimulus involved in sensory perception of sound	4	13	30.7692307692308	0.00461861474431657	0.0626262165925783	1	1	0.988851583651156	0.999989987113883	0.56373150008354
down	E2F8; WNT1; PCK2; ANXA1;	GO:0070365~hepatocyte differentiation	4	13	30.7692307692308	0.00461861474431657	0.0626262165925783	1	1	0.988851583651156	0.999989987113883	0.56373150008354
down	DLG1; DLG3; LRRC1; DLG2;	GO:0097120~receptor localization to synapse	4	13	30.7692307692308	0.00461861474431657	0.0626262165925783	1	1	0.988851583651156	0.999989987113883	0.56373150008354
down	ALDH1L1; CA6; AHCY; ALDH1L2; SHMT1;	GO:0006730~one-carbon metabolic process	5	22	22.7272727272727	0.00467933555812328	0.0627030964788519	1	1	0.989977945208234	0.999989987113883	0.564423536358016
down	KRT3; PPL; DSP; EPPK1; EVPL;	GO:0045104~intermediate filament cytoskeleton organization	5	22	22.7272727272727	0.00467933555812328	0.0627030964788519	1	1	0.989977945208234	0.999989987113883	0.564423536358016
down	TNFSF11; JPH2; TRPV6; S100A14; TRPV5;	GO:0055074~calcium ion homeostasis	5	22	22.7272727272727	0.00467933555812328	0.0627030964788519	1	1	0.989977945208234	0.999989987113883	0.564423536358016
down	GSTA4; GSTP1; MGST1; MGST2; GSTO2;	GO:1901687~glutathione derivative biosynthetic process	5	22	22.7272727272727	0.00467933555812328	0.0627030964788519	1	1	0.989977945208234	0.999989987113883	0.564423536358016
down	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.00501545888827648	0.0652869448428219	1	1	0.995285590651149	0.999989987113883	0.587682113890892
down	CD9; MAPK10; LRP11;	GO:0009414~response to water deprivation	3	6	50	0.00501545888827648	0.0652869448428219	1	1	0.995285590651149	0.999989987113883	0.587682113890892
down	NTRK1; BDNF; NTRK2;	GO:0042490~mechanoreceptor differentiation	3	6	50	0.00501545888827648	0.0652869448428219	1	1	0.995285590651149	0.999989987113883	0.587682113890892
down	HRH2; RARB; RARG;	GO:0048732~gland development	3	6	50	0.00501545888827648	0.0652869448428219	1	1	0.995285590651149	0.999989987113883	0.587682113890892
down	CLDN4; AKR1C3; KCNQ1;	GO:0070293~renal absorption	3	6	50	0.00501545888827648	0.0652869448428219	1	1	0.995285590651149	0.999989987113883	0.587682113890892
down	DSP; TJP1; CGNL1;	GO:0150105~protein localization to cell-cell junction	3	6	50	0.00501545888827648	0.0652869448428219	1	1	0.995285590651149	0.999989987113883	0.587682113890892
down	EGFR; ERBB2; LGMN;	GO:1901185~negative regulation of ERBB signaling pathway	3	6	50	0.00501545888827648	0.0652869448428219	1	1	0.995285590651149	0.999989987113883	0.587682113890892
down	SLC7A1; SLC7A2; SLC7A3;	GO:1903401~L-lysine transmembrane transport	3	6	50	0.00501545888827648	0.0652869448428219	1	1	0.995285590651149	0.999989987113883	0.587682113890892
down	IFNG; KIT; OSM; FGFR3; FLT3; PTK6; IL18; STAP2; TNFSF18;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	9	69	13.0434782608696	0.00509881776174126	0.0661829450783281	1	1	0.996619306685522	0.999989987113883	0.595747483065645
down	ABLIM1; ABLIM3; KIT; P2RY12; ARHGEF4; ABLIM2;	GO:0030032~lamellipodium assembly	6	33	18.1818181818182	0.00519527092116101	0.0672433361272999	1	1	0.997998233432925	0.999989987113883	0.605292620377721
down	MATN2; SORBS2; RIPPLY3; MRPS10; PDGFRL; FAM189A2; KRT24; PRICKLE4; TMEM35A; TTC39A; TRAPPC3L; GGT6; INO80C; BTNL3; DLEU7; KNDC1; TMPRSS11B; KRT73; DMRTC2; IL22RA1; SAMD12; GIPC2; S100Z; TMEM54; CDCA3; P2RY13; H2AFJ; TMEM106C; GPR87; GSDMC; PRRG4; UACA; HDHD2; RNF39; ADAMTS10; SERHL; NYNRIN; TRIM10; EPHA6; FETUB; AMMECR1;	GO:0008150~biological_process	41	603	6.79933665008292	0.00525538635375356	0.0678287258575105	1	1	0.998943783202573	0.999989987113883	0.610562021096784
down	CEACAM4; ANXA1; ANXA3; ICAM3; IRF8; SLAMF1; CEBPE; TYRO3;	GO:0006909~phagocytosis	8	57	14.0350877192982	0.00546991931566976	0.0694631503063958	1	1	0.999989987113883	0.999989987113883	0.625274334828547
down	CYP7B1; EGFR; TGFA; ERBB2; BMP4; SCN5A; EYA1; ESRP2;	GO:0050679~positive regulation of epithelial cell proliferation	8	57	14.0350877192982	0.00546991931566976	0.0694631503063958	1	1	0.999989987113883	0.999989987113883	0.625274334828547
down	PRMT5; CDC25C; MKI67; NEK2; PKMYT1;	GO:0007088~regulation of mitotic nuclear division	5	23	21.7391304347826	0.00550399413095015	0.0694631503063958	1	1	0.999989987113883	0.999989987113883	0.625274334828547
down	IL2RA; IGFBP2; CD24; IL18; HHLA2;	GO:0042104~positive regulation of activated T cell proliferation	5	23	21.7391304347826	0.00550399413095015	0.0694631503063958	1	1	0.999989987113883	0.999989987113883	0.625274334828547
down	ANXA1; GSTP1; SSTR3; FLT3; STC1;	GO:0071385~cellular response to glucocorticoid stimulus	5	23	21.7391304347826	0.00550399413095015	0.0694631503063958	1	1	0.999989987113883	0.999989987113883	0.625274334828547
down	MYO1B; AIF1; BAIAP2; AIF1L; PLS3; PLS1; BAIAP2L2;	GO:0051017~actin filament bundle assembly	7	45	15.5555555555556	0.00558258776346765	0.0702604139512669	1	1	0.999989987113883	0.999989987113883	0.632450924042121
down	GSTP1; CX3CL1; FFAR4; ERRFI1;	GO:0032691~negative regulation of interleukin-1 beta production	4	14	28.5714285714286	0.00574448900964375	0.070926536390073	1	1	0.999989987113883	0.999989987113883	0.638447042314927
down	IL27; TLR9; TLR8; TLR7;	GO:0045078~positive regulation of interferon-gamma biosynthetic process	4	14	28.5714285714286	0.00574448900964375	0.070926536390073	1	1	0.999989987113883	0.999989987113883	0.638447042314927
down	LGALS3; EDN2; CX3CL1; CXCL17;	GO:0048246~macrophage chemotaxis	4	14	28.5714285714286	0.00574448900964375	0.070926536390073	1	1	0.999989987113883	0.999989987113883	0.638447042314927
down	GCNT3; ADRA2A; KCNQ1; TJP2;	GO:0050892~intestinal absorption	4	14	28.5714285714286	0.00574448900964375	0.070926536390073	1	1	0.999989987113883	0.999989987113883	0.638447042314927
down	ADRA2A; STC1; LILRB2; LILRB1;	GO:0051926~negative regulation of calcium ion transport	4	14	28.5714285714286	0.00574448900964375	0.070926536390073	1	1	0.999989987113883	0.999989987113883	0.638447042314927
down	ANXA3; EPHA2; P2RY1; SOX2;	GO:0070848~response to growth factor	4	14	28.5714285714286	0.00574448900964375	0.070926536390073	1	1	0.999989987113883	0.999989987113883	0.638447042314927
down	COBL; BMP7; PTN; PACSIN1;	GO:1900006~positive regulation of dendrite development	4	14	28.5714285714286	0.00574448900964375	0.070926536390073	1	1	0.999989987113883	0.999989987113883	0.638447042314927
down	KALRN; ERBB2; CACNB2; PPFIBP2; PDZRN3; UNC13B;	GO:0007528~neuromuscular junction development	6	34	17.6470588235294	0.00590046831091762	0.0726554962825423	1	1	0.999989987113883	0.999989987113883	0.654010319274588
down	MS4A1; CCR2; BLNK; FOXJ1; JCHAIN; IFNG; TRAF3IP2; AIRE;	GO:0006959~humoral immune response	8	58	13.7931034482759	0.00600196496963457	0.0737060711634908	1	1	0.999989987113883	0.999989987113883	0.663467096097625
down	PLPP3; CCNB1; FBLN1; BDKRB1; XDH; PTPN13; ANGPT1; WWTR1; PPARGC1A;	GO:0001933~negative regulation of protein phosphorylation	9	71	12.6760563380282	0.00602361990943234	0.0737731513639079	1	1	0.999989987113883	0.999989987113883	0.66407092024771
down	DKK1; DNAJB1; SSTR3; SOX2; POU3F1; PPARGC1A; NOTCH3;	GO:0030900~forebrain development	7	46	15.2173913043478	0.0062054765695333	0.0755939873015874	1	1	0.999989987113883	0.999989987113883	0.680461221792378
down	ADRA2A; IGFBP2; AIF1; RAMP2; AVPR2; GNRHR; AVPR1A;	GO:0032870~cellular response to hormone stimulus	7	46	15.2173913043478	0.0062054765695333	0.0755939873015874	1	1	0.999989987113883	0.999989987113883	0.680461221792378
down	CYP2E1; HPGD; ALOX12; EPHX2; ELOVL6;	GO:0042759~long-chain fatty acid biosynthetic process	5	24	20.8333333333333	0.00642608875611295	0.0772487081077852	1	1	0.999989987113883	0.999989987113883	0.695356233706731
down	PF4; IRF8; IRF4; BATF; GBP6;	GO:0042832~defense response to protozoan	5	24	20.8333333333333	0.00642608875611295	0.0772487081077852	1	1	0.999989987113883	0.999989987113883	0.695356233706731
down	HPN; TIFAB; MYO3B; FRZB; EYA1;	GO:0090103~cochlea morphogenesis	5	24	20.8333333333333	0.00642608875611295	0.0772487081077852	1	1	0.999989987113883	0.999989987113883	0.695356233706731
down	CLDN4; ANXA1; ADRA2A; HBEGF; DUOX1;	GO:0090303~positive regulation of wound healing	5	24	20.8333333333333	0.00642608875611295	0.0772487081077852	1	1	0.999989987113883	0.999989987113883	0.695356233706731
down	HSPB1; GSTP1; CEACAM1; EPHA1; SFN; DEPTOR; DBNDD2; WWTR1; GSKIP;	GO:0006469~negative regulation of protein kinase activity	9	72	12.5	0.00653188210224342	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	MEIS1; BMP7; SLC6A4; SOX2; IRX3; OLIG2; ISL2; NOTCH3;	GO:0045665~negative regulation of neuron differentiation	8	59	13.5593220338983	0.00657239913504537	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	CD300LD; IDO2; CD300LF; CTLA4; IRF8; IRF4;	GO:0002376~immune system process	6	35	17.1428571428571	0.00667290120058361	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	PF4; GATA1; CX3CL1; UNC5B; EYA2; EYA1;	GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	6	35	17.1428571428571	0.00667290120058361	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	CRHBP; RXFP2; RARB; THRB; PPARD; RARG; PPARG;	GO:0009755~hormone-mediated signaling pathway	7	47	14.8936170212766	0.00687868562188054	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	GREM1; DKK1; WNT1; SOSTDC1; RBPMS2; SFRP2; CHRDL1;	GO:0030514~negative regulation of BMP signaling pathway	7	47	14.8936170212766	0.00687868562188054	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	GATA1; TAL1; CDKN2B;	GO:0030219~megakaryocyte differentiation	3	7	42.8571428571429	0.00694431867958722	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	ALOX15B; PRLR; CD24;	GO:0030856~regulation of epithelial cell differentiation	3	7	42.8571428571429	0.00694431867958722	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	NFASC; CD9; ANK2;	GO:0030913~paranodal junction assembly	3	7	42.8571428571429	0.00694431867958722	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	BDNF; SLC6A1; CNR2;	GO:0032229~negative regulation of synaptic transmission, GABAergic	3	7	42.8571428571429	0.00694431867958722	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	GSTP1; FOXM1; PBK;	GO:0032873~negative regulation of stress-activated MAPK cascade	3	7	42.8571428571429	0.00694431867958722	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	GSTP1; CEACAM1; FLT3;	GO:0035726~common myeloid progenitor cell proliferation	3	7	42.8571428571429	0.00694431867958722	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	BMP4; APCDD1; WNT10A;	GO:0042487~regulation of odontogenesis of dentin-containing tooth	3	7	42.8571428571429	0.00694431867958722	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	3	7	42.8571428571429	0.00694431867958722	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	VIL1; DSTN; SCIN;	GO:0051014~actin filament severing	3	7	42.8571428571429	0.00694431867958722	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	EREG; RBPMS2; PRDM6;	GO:0051151~negative regulation of smooth muscle cell differentiation	3	7	42.8571428571429	0.00694431867958722	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	NEK2; SPAG5; RACGAP1;	GO:0051988~regulation of attachment of spindle microtubules to kinetochore	3	7	42.8571428571429	0.00694431867958722	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	FOXJ1; RARG; RARB;	GO:0060429~epithelium development	3	7	42.8571428571429	0.00694431867958722	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	SPRY1; BMP4; RDH10;	GO:0060449~bud elongation involved in lung branching	3	7	42.8571428571429	0.00694431867958722	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	CYP7B1; RARG; FOXA1;	GO:0060740~prostate gland epithelium morphogenesis	3	7	42.8571428571429	0.00694431867958722	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	UNC13B; RIMS1; IGSF9B;	GO:0097151~positive regulation of inhibitory postsynaptic potential	3	7	42.8571428571429	0.00694431867958722	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	ANXA8; SPINK5; ANXA8L1;	GO:1900004~negative regulation of serine-type endopeptidase activity	3	7	42.8571428571429	0.00694431867958722	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	BDNF; NTRK2; DOCK3;	GO:1903997~positive regulation of non-membrane spanning protein tyrosine kinase activity	3	7	42.8571428571429	0.00694431867958722	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	RAD51; RECQL5; RECQL4; MCM4;	GO:0006268~DNA unwinding involved in DNA replication	4	15	26.6666666666667	0.00703934501399228	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	ELOVL7; SCD; SCD5; ELOVL6;	GO:0006636~unsaturated fatty acid biosynthetic process	4	15	26.6666666666667	0.00703934501399228	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	GGCT; GGT5; GGT6; MGST2;	GO:0006750~glutathione biosynthetic process	4	15	26.6666666666667	0.00703934501399228	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	NGFR; SEMA3A; NRTN; BDNF;	GO:0021675~nerve development	4	15	26.6666666666667	0.00703934501399228	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	CCL21; NCKAP1L; SFRP2; P2RY12;	GO:0033630~positive regulation of cell adhesion mediated by integrin	4	15	26.6666666666667	0.00703934501399228	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	NLRP6; TYRO3; IRF4; TLR9;	GO:0034122~negative regulation of toll-like receptor signaling pathway	4	15	26.6666666666667	0.00703934501399228	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	LGALS3; EPHA3; LILRB1; PACSIN1;	GO:0045806~negative regulation of endocytosis	4	15	26.6666666666667	0.00703934501399228	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	IFNG; FCER2; KDR; TLR9;	GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process	4	15	26.6666666666667	0.00703934501399228	0.0774668016515672	1	1	0.999989987113883	0.999989987113883	0.697319408352817
down	S100B; ANXA3; GOT1; IGFBP2; IL1RN; ALDH3A1; AIF1; HSD11B2;	GO:0051384~response to glucocorticoid	8	60	13.3333333333333	0.00718291012856165	0.0788562374595828	1	1	0.999989987113883	0.999989987113883	0.709826450530026
up	CXCL11; S100A9; GJB1;	GO:0007267~cell-cell signaling	3	230	1.30434782608696	0.00724491779843883	0.0355152440594634	1	1	0.459335057432142	0.618845478388709	0.220684265522885
down	NPR3; CCR2; ADGRV1; P2RY13; GPR87;	GO:0007194~negative regulation of adenylate cyclase activity	5	25	20	0.00745123943720716	0.0810211142623289	1	1	0.999989987113883	0.999989987113883	0.729313644774053
down	GOT1; PYCR1; ASPA; ASPG; GPT2;	GO:0008652~cellular amino acid biosynthetic process	5	25	20	0.00745123943720716	0.0810211142623289	1	1	0.999989987113883	0.999989987113883	0.729313644774053
down	DKK1; BDKRB2; CNKSR3; GPD1L; INPP5J;	GO:0033137~negative regulation of peptidyl-serine phosphorylation	5	25	20	0.00745123943720716	0.0810211142623289	1	1	0.999989987113883	0.999989987113883	0.729313644774053
down	GJA1; PTN; GJB2; STC1; PPARD;	GO:0046697~decidualization	5	25	20	0.00745123943720716	0.0810211142623289	1	1	0.999989987113883	0.999989987113883	0.729313644774053
down	RAMP2; TRPM2; CCR5; BSPRY; CACNG6; TRPV6; NMUR1; TRPV4; TRPV5;	GO:0006816~calcium ion transport	9	74	12.1621621621622	0.00764648140261825	0.0827490956539876	1	1	0.999989987113883	0.999989987113883	0.744868113733489
down	ORM1; GSTP1; BPI; CX3CL1; ARG2; SLAMF1; CLEC4A;	GO:0032720~negative regulation of tumor necrosis factor production	7	49	14.2857142857143	0.00838545558607717	0.0895031617710759	1	1	0.999989987113883	0.999989987113883	0.805665013674286
down	EDIL3; PTN; NPNT; EGFL6; SMOC2; VIT;	GO:0010811~positive regulation of cell-substrate adhesion	6	37	16.2162162162162	0.00843332818555043	0.0895031617710759	1	1	0.999989987113883	0.999989987113883	0.805665013674286
down	EGFR; SRD5A1; CCNA2; CRHBP; SSTR3; PPARGC1A;	GO:0071392~cellular response to estradiol stimulus	6	37	16.2162162162162	0.00843332818555043	0.0895031617710759	1	1	0.999989987113883	0.999989987113883	0.805665013674286
down	PTGES; EDN2; PLA2G4A; MGST1;	GO:0001516~prostaglandin biosynthetic process	4	16	25	0.00851303160454653	0.0895031617710759	1	1	0.999989987113883	0.999989987113883	0.805665013674286
down	GOT1; KYAT3; GPT2; L2HGDH;	GO:0006103~2-oxoglutarate metabolic process	4	16	25	0.00851303160454653	0.0895031617710759	1	1	0.999989987113883	0.999989987113883	0.805665013674286
down	CYP2E1; MGST1; FLT3; MGST2;	GO:0010243~response to organonitrogen compound	4	16	25	0.00851303160454653	0.0895031617710759	1	1	0.999989987113883	0.999989987113883	0.805665013674286
down	SPRY1; NGFR; WNT4; SULF1;	GO:0040037~negative regulation of fibroblast growth factor receptor signaling pathway	4	16	25	0.00851303160454653	0.0895031617710759	1	1	0.999989987113883	0.999989987113883	0.805665013674286
down	EDN2; KEL; BDKRB2; SLC6A4;	GO:0042310~vasoconstriction	4	16	25	0.00851303160454653	0.0895031617710759	1	1	0.999989987113883	0.999989987113883	0.805665013674286
down	BMP4; BMP7; CDKN2B; DYNLL1;	GO:0042326~negative regulation of phosphorylation	4	16	25	0.00851303160454653	0.0895031617710759	1	1	0.999989987113883	0.999989987113883	0.805665013674286
down	ALOX12; NOX5; DUOX1; NOXA1;	GO:0042554~superoxide anion generation	4	16	25	0.00851303160454653	0.0895031617710759	1	1	0.999989987113883	0.999989987113883	0.805665013674286
down	GJA1; WNT4; EPPK1; WFDC1;	GO:0061045~negative regulation of wound healing	4	16	25	0.00851303160454653	0.0895031617710759	1	1	0.999989987113883	0.999989987113883	0.805665013674286
down	EGFR; GJA1; BMP7; NYAP1; PACSIN1; NCKAP1; NCKAP1L; BDNF;	GO:0048812~neuron projection morphogenesis	8	62	12.9032258064516	0.00853095153907713	0.0895031617710759	1	1	0.999989987113883	0.999989987113883	0.805665013674286
down	RECQL5; DNTT; KPNA2; DNASE1L3; TREX2;	GO:0006259~DNA metabolic process	5	26	19.2307692307692	0.00858491696531172	0.0895031617710759	1	1	0.999989987113883	0.999989987113883	0.805665013674286
down	ANXA9; RAPSN; CHRFAM7A; CHRNB4; CHRNG;	GO:0007271~synaptic transmission, cholinergic	5	26	19.2307692307692	0.00858491696531172	0.0895031617710759	1	1	0.999989987113883	0.999989987113883	0.805665013674286
down	IFNG; CD40LG; IRF8; SCIMP; TLR9;	GO:0032735~positive regulation of interleukin-12 production	5	26	19.2307692307692	0.00858491696531172	0.0895031617710759	1	1	0.999989987113883	0.999989987113883	0.805665013674286
down	MET; TJP1; CGNL1; PHLDB2; ARHGAP28;	GO:0051497~negative regulation of stress fiber assembly	5	26	19.2307692307692	0.00858491696531172	0.0895031617710759	1	1	0.999989987113883	0.999989987113883	0.805665013674286
down	TMEM132D; DLG2; SH3RF2; DLG3; PKMYT1; SH2D4A; CAMSAP3;	GO:0010923~negative regulation of phosphatase activity	7	50	14	0.0092236978245902	0.0934573132717836	1	1	0.999989987113883	0.999989987113883	0.841258410151564
down	GIPC1; PTN; BDNF; HRH2; CX3CL1; BAIAP2; RIMS1;	GO:0048167~regulation of synaptic plasticity	7	50	14	0.0092236978245902	0.0934573132717836	1	1	0.999989987113883	0.999989987113883	0.841258410151564
down	ADCY5; P2RY1; P2RY12;	GO:0001973~G protein-coupled adenosine receptor signaling pathway	3	8	37.5	0.00925508606052783	0.0934573132717836	1	1	0.999989987113883	0.999989987113883	0.841258410151564
down	ADRA2A; P2RY1; P2RY12;	GO:0010700~negative regulation of norepinephrine secretion	3	8	37.5	0.00925508606052783	0.0934573132717836	1	1	0.999989987113883	0.999989987113883	0.841258410151564
down	IL18RAP; IL18; LILRA2;	GO:0032635~interleukin-6 production	3	8	37.5	0.00925508606052783	0.0934573132717836	1	1	0.999989987113883	0.999989987113883	0.841258410151564
down	CTNND1; MET; CDH1;	GO:0035635~entry of bacterium into host cell	3	8	37.5	0.00925508606052783	0.0934573132717836	1	1	0.999989987113883	0.999989987113883	0.841258410151564
down	TLR9; TLR8; TLR7;	GO:0045359~positive regulation of interferon-beta biosynthetic process	3	8	37.5	0.00925508606052783	0.0934573132717836	1	1	0.999989987113883	0.999989987113883	0.841258410151564
down	BDNF; EFNA5; LPAR3;	GO:0048672~positive regulation of collateral sprouting	3	8	37.5	0.00925508606052783	0.0934573132717836	1	1	0.999989987113883	0.999989987113883	0.841258410151564
down	SCNN1A; SCNN1B; TRPV4;	GO:0050891~multicellular organismal water homeostasis	3	8	37.5	0.00925508606052783	0.0934573132717836	1	1	0.999989987113883	0.999989987113883	0.841258410151564
down	COBL; PLS3; PLS1;	GO:0051639~actin filament network formation	3	8	37.5	0.00925508606052783	0.0934573132717836	1	1	0.999989987113883	0.999989987113883	0.841258410151564
down	ATP2C2; MSX1; WNT4;	GO:0061180~mammary gland epithelium development	3	8	37.5	0.00925508606052783	0.0934573132717836	1	1	0.999989987113883	0.999989987113883	0.841258410151564
down	KLF4; SPI1; PPARG;	GO:0061614~pri-miRNA transcription by RNA polymerase II	3	8	37.5	0.00925508606052783	0.0934573132717836	1	1	0.999989987113883	0.999989987113883	0.841258410151564
down	RAB27B; HSPB1; DLG2;	GO:0099641~anterograde axonal protein transport	3	8	37.5	0.00925508606052783	0.0934573132717836	1	1	0.999989987113883	0.999989987113883	0.841258410151564
down	C3; LPL; GGT5; ECHDC3; CYP4F11; CPT1C; PPARG; PPARD;	GO:0006631~fatty acid metabolic process	8	63	12.6984126984127	0.00927188445979943	0.0934573132717836	1	1	0.999989987113883	0.999989987113883	0.841258410151564
down	IGFBP2; AHCY; ALDH3A1; SLC6A4; PPARG; AKR1C3; SFRP2; SLC27A4;	GO:0007584~response to nutrient	8	63	12.6984126984127	0.00927188445979943	0.0934573132717836	1	1	0.999989987113883	0.999989987113883	0.841258410151564
down	NGFR; ADRA2A; PHACTR4; EPS8L1; CNKSR1; EPS8L2; CDC42EP1; RHOJ; C15orf62;	GO:0007266~Rho protein signal transduction	9	77	11.6883116883117	0.00958288066150226	0.0943163488837107	1	1	0.999989987113883	0.999989987113883	0.848991041316037
down	LILRA5; ANK2; CACNB2; LILRA2; LPAR3;	GO:0051928~positive regulation of calcium ion transport	5	27	18.5185185185185	0.00983241852260897	0.0943163488837107	1	1	0.999989987113883	0.999989987113883	0.848991041316037
down	BDKRB2; CHRNB4; MYH11; NMUR1;	GO:0006939~smooth muscle contraction	4	17	23.5294117647059	0.0101746678100415	0.0961738310011392	1	1	0.999989987113883	0.999989987113883	0.865711214390653
down	ALOX15B; PF4; LPL; IL18;	GO:0010744~positive regulation of macrophage derived foam cell differentiation	4	17	23.5294117647059	0.0101746678100415	0.0961738310011392	1	1	0.999989987113883	0.999989987113883	0.865711214390653
down	PIR; BMP4; MT1G; PPARG;	GO:0030224~monocyte differentiation	4	17	23.5294117647059	0.0101746678100415	0.0961738310011392	1	1	0.999989987113883	0.999989987113883	0.865711214390653
down	KIT; GATA1; TAL1; KDR;	GO:0035162~embryonic hemopoiesis	4	17	23.5294117647059	0.0101746678100415	0.0961738310011392	1	1	0.999989987113883	0.999989987113883	0.865711214390653
down	AQP3; GRHL1; SERPINB13; ERRFI1;	GO:0045616~regulation of keratinocyte differentiation	4	17	23.5294117647059	0.0101746678100415	0.0961738310011392	1	1	0.999989987113883	0.999989987113883	0.865711214390653
down	NRG2; BARX1; BARX2; SPRY1;	GO:0048513~animal organ development	4	17	23.5294117647059	0.0101746678100415	0.0961738310011392	1	1	0.999989987113883	0.999989987113883	0.865711214390653
down	CCL21; AIF1; P2RY12; CCL26;	GO:0050921~positive regulation of chemotaxis	4	17	23.5294117647059	0.0101746678100415	0.0961738310011392	1	1	0.999989987113883	0.999989987113883	0.865711214390653
down	AURKA; BIRC5; MAP3K13; BUB1; KALRN; BUB1B; CCNB2; ERBB2; NTRK1; CDK1; NPR1; CCNO; CCNE1; LTK; MATK; NEK2; PLK1; MAPK10; RIPK4; CCNA1; PTK6; MAPK6; CDC42BPG; MYO3B; AURKB; WNK4; ALPK3; PKMYT1; HSPB8; HUNK; MELK; PHKA1; PRKAA2;	GO:0006468~protein phosphorylation	33	482	6.84647302904564	0.010349982902359	0.0976284101514443	1	1	0.999989987113883	0.999989987113883	0.878804646039675
down	DHCR24; LAMC3; BARX2; LAMB4; NTN1; BARX1;	GO:0009888~tissue development	6	39	15.3846153846154	0.0105038563786075	0.0984682503311437	1	1	0.999989987113883	0.999989987113883	0.886364489027036
down	LILRA5; GREM1; TAL1; ERBB3; CD24; DLG3;	GO:0061098~positive regulation of protein tyrosine kinase activity	6	39	15.3846153846154	0.0105038563786075	0.0984682503311437	1	1	0.999989987113883	0.999989987113883	0.886364489027036
up	S100A8; S100A9; S100A12; FCER1G;	GO:0045087~innate immune response	4	505	0.792079207920792	0.0108777953058957	0.0399531541974792	1	1	0.543889765294786	0.618845478388709	0.248260506801836
down	NEK2; RAD51; HORMAD1; PSMA8; RAD54L; RBBP8; DPEP3; EXO1;	GO:0051321~meiotic cell cycle	8	65	12.3076923076923	0.0108960705101152	0.101726428778862	1	1	0.999989987113883	0.999989987113883	0.91569306615986
down	SLC25A5; GJA1; SLC25A43; SLC25A21; SLC25A23;	GO:0015867~ATP transport	5	28	17.8571428571429	0.01119884533115	0.10391433671837	1	1	0.999989987113883	0.999989987113883	0.935387575774052
down	RARB; BMP4; RARG; MSX1; PITX1;	GO:0035116~embryonic hindlimb morphogenesis	5	28	17.8571428571429	0.01119884533115	0.10391433671837	1	1	0.999989987113883	0.999989987113883	0.935387575774052
down	CCNB2; NCKAP1L; SPNS2; GPR174; SIT1;	GO:0043029~T cell homeostasis	5	28	17.8571428571429	0.01119884533115	0.10391433671837	1	1	0.999989987113883	0.999989987113883	0.935387575774052
down	AURKA; HMMR; CDK1; NEK2; PLK1; YWHAE; DYNLL1; TUBB4B; TPX2;	GO:0010389~regulation of G2/M transition of mitotic cell cycle	9	80	11.25	0.0118678075795474	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	FCN1; KRT1; MASP1;	GO:0001867~complement activation, lectin pathway	3	9	33.3333333333333	0.011961857973714	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	PLA2G4A; CYP2J2; CYP4F22;	GO:0006690~icosanoid metabolic process	3	9	33.3333333333333	0.011961857973714	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	HPGD; PTGFR; MAFF;	GO:0007567~parturition	3	9	33.3333333333333	0.011961857973714	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	VWF; AVPR2; P2RY12;	GO:0007599~hemostasis	3	9	33.3333333333333	0.011961857973714	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	PLK1; CDC6; UBE2C;	GO:0030071~regulation of mitotic metaphase/anaphase transition	3	9	33.3333333333333	0.011961857973714	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	TPPP; RAB11A; DLG1;	GO:0030953~astral microtubule organization	3	9	33.3333333333333	0.011961857973714	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	FUT6; FUT2; FUT7;	GO:0042355~L-fucose catabolic process	3	9	33.3333333333333	0.011961857973714	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	BPI; FCGR2B; ADGRF5;	GO:0043031~negative regulation of macrophage activation	3	9	33.3333333333333	0.011961857973714	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	ADRA2A; ANK2; DLG1;	GO:0043268~positive regulation of potassium ion transport	3	9	33.3333333333333	0.011961857973714	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	LOX; MYH11; MFAP4;	GO:0048251~elastic fiber assembly	3	9	33.3333333333333	0.011961857973714	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	IGHD; ORM1; ORM2;	GO:0050716~positive regulation of interleukin-1 secretion	3	9	33.3333333333333	0.011961857973714	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	DLG1; PARD3; PARD3B;	GO:0051660~establishment of centrosome localization	3	9	33.3333333333333	0.011961857973714	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	AIF1; BAIAP2; BAIAP2L2;	GO:0051764~actin crosslink formation	3	9	33.3333333333333	0.011961857973714	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	RAB11A; LAMP3; LAMP5;	GO:0072594~establishment of protein localization to organelle	3	9	33.3333333333333	0.011961857973714	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	ATP1B1; KCNQ1; YWHAE;	GO:0086013~membrane repolarization during cardiac muscle cell action potential	3	9	33.3333333333333	0.011961857973714	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	DLGAP5; WWC1; HEYL; NOTCH3;	GO:0007221~positive regulation of transcription of Notch receptor target	4	18	22.2222222222222	0.0120326099218828	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	BMP4; AVPR2; AVPR1A; SCN5A;	GO:0021537~telencephalon development	4	18	22.2222222222222	0.0120326099218828	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	POU3F1; NTRK2; ADGRG6; PARD3;	GO:0022011~myelination in peripheral nervous system	4	18	22.2222222222222	0.0120326099218828	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	GSTP1; ALOX12; CYP2J2; ALOX15B;	GO:0043651~linoleic acid metabolic process	4	18	22.2222222222222	0.0120326099218828	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	GSTP1; PPARG; CNN1; MYOCD;	GO:1904706~negative regulation of vascular smooth muscle cell proliferation	4	18	22.2222222222222	0.0120326099218828	0.10644771029922	1	1	0.999989987113883	0.999989987113883	0.958191803247916
down	CCL21; CTLA4; CD24; CD40LG; CD80; HHLA2; ICOS;	GO:0031295~T cell costimulation	7	53	13.2075471698113	0.0121056250001115	0.10667935686752	1	1	0.999989987113883	0.999989987113883	0.960276975792934
down	NFASC; ERBB2; MAL; KEL; OLIG2; ADGRG6; PMP22;	GO:0042552~myelination	7	53	13.2075471698113	0.0121056250001115	0.10667935686752	1	1	0.999989987113883	0.999989987113883	0.960276975792934
down	SPRY1; BMP7; IRX3; RDH10; EYA1;	GO:0001656~metanephros development	5	29	17.2413793103448	0.0126890823537927	0.110324233591102	1	1	0.999989987113883	0.999989987113883	0.993086427406011
down	PRLR; FDXR; DHRS11; SDR42E1; SRD5A1;	GO:0006694~steroid biosynthetic process	5	29	17.2413793103448	0.0126890823537927	0.110324233591102	1	1	0.999989987113883	0.999989987113883	0.993086427406011
down	P2RX1; MYH14; GPR88; SCN5A; SCN7A;	GO:0019228~neuronal action potential	5	29	17.2413793103448	0.0126890823537927	0.110324233591102	1	1	0.999989987113883	0.999989987113883	0.993086427406011
down	GIPC1; GOT1; CDKN2B; NPNT; MYOCD;	GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway	5	29	17.2413793103448	0.0126890823537927	0.110324233591102	1	1	0.999989987113883	0.999989987113883	0.993086427406011
down	CD19; BDKRB1; CX3CL1; CEMIP; F2RL3;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	5	29	17.2413793103448	0.0126890823537927	0.110324233591102	1	1	0.999989987113883	0.999989987113883	0.993086427406011
down	CRHBP; DLG1; DLG2; DLG3; PPARGC1A;	GO:2000310~regulation of NMDA receptor activity	5	29	17.2413793103448	0.0126890823537927	0.110324233591102	1	1	0.999989987113883	0.999989987113883	0.993086427406011
down	UBE2C; AURKA; BUB1B; CDK1; CCNB1; PLK1; CDC20; PSMA8; AURKB;	GO:0031145~anaphase-promoting complex-dependent catabolic process	9	81	11.1111111111111	0.0127129549243478	0.110324233591102	1	1	0.999989987113883	0.999989987113883	0.993086427406011
up	GJB1; PSMB4; SLC44A4;	GO:0055085~transmembrane transport	3	285	1.05263157894737	0.0128389818168587	0.0420345191045197	1	1	0.590593163575501	0.618845478388709	0.261193671079865
down	PLD2; PLA2G4A; PLD1; GPD1L; LIPH; PLA2G2D;	GO:0006654~phosphatidic acid biosynthetic process	6	41	14.6341463414634	0.0129108916660704	0.111405345512532	1	1	0.999989987113883	0.999989987113883	1
down	NTRK1; NGFR; GJA1; VCAM1; FCGR2B; LGMN;	GO:1904646~cellular response to amyloid-beta	6	41	14.6341463414634	0.0129108916660704	0.111405345512532	1	1	0.999989987113883	0.999989987113883	1
down	SPTLC1; SPNS2; TEX2; TECR;	GO:0006665~sphingolipid metabolic process	4	19	21.0526315789474	0.0140944282819707	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	DLG1; DLG2; DLG3; LRRC1;	GO:0009790~embryo development	4	19	21.0526315789474	0.0140944282819707	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	VWF; PPARD; ANGPT1; TTYH1;	GO:0031589~cell-substrate adhesion	4	19	21.0526315789474	0.0140944282819707	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	RARB; RARG; PTN; DLG1;	GO:0031641~regulation of myelination	4	19	21.0526315789474	0.0140944282819707	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	TPPP; S100B; PARD3; ZNF488;	GO:0031643~positive regulation of myelination	4	19	21.0526315789474	0.0140944282819707	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	ELOVL7; HACD2; ELOVL6; TECR;	GO:0035338~long-chain fatty-acyl-CoA biosynthetic process	4	19	21.0526315789474	0.0140944282819707	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	SOCS6; KLF4; PIK3R6; PIK3R5;	GO:0043551~regulation of phosphatidylinositol 3-kinase activity	4	19	21.0526315789474	0.0140944282819707	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	SNCG; CHRNB4; RIMS1; SNCAIP;	GO:0046928~regulation of neurotransmitter secretion	4	19	21.0526315789474	0.0140944282819707	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	BMP4; OLIG2; ZNF521; NOTCH3;	GO:0048663~neuron fate commitment	4	19	21.0526315789474	0.0140944282819707	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	TRIP13; RAD54B; RAD51; MND1; RAD54L;	GO:0007131~reciprocal meiotic recombination	5	30	16.6666666666667	0.0143077800377831	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	PTN; LRRC1; DLG1; DLG3; DLG2;	GO:0043113~receptor clustering	5	30	16.6666666666667	0.0143077800377831	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	TXN; MMP8; PPARG; IRF4; MYOCD;	GO:0043388~positive regulation of DNA binding	5	30	16.6666666666667	0.0143077800377831	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	MATN2; NTRK1; CDK1; AIF1; P2RY12;	GO:0048678~response to axon injury	5	30	16.6666666666667	0.0143077800377831	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	FGFR3; MSX1; SFRP2; RARG; RARB;	GO:0060349~bone morphogenesis	5	30	16.6666666666667	0.0143077800377831	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	CDC45; CDC6; CDT1;	GO:0000076~DNA replication checkpoint	3	10	30	0.0150748489846205	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	AVPR2; AVPR1A; NMU;	GO:0003084~positive regulation of systemic arterial blood pressure	3	10	30	0.0150748489846205	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	OPHN1; NTN1; P2RY12;	GO:0006930~substrate-dependent cell migration, cell extension	3	10	30	0.0150748489846205	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	ALOX15B; FKBP4; ANXA1;	GO:0030850~prostate gland development	3	10	30	0.0150748489846205	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	IL18RAP; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	3	10	30	0.0150748489846205	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	GREM1; GSTP1; PRDX1;	GO:0032872~regulation of stress-activated MAPK cascade	3	10	30	0.0150748489846205	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	SRD5A1; AKR1C3; AKR1C1;	GO:0042448~progesterone metabolic process	3	10	30	0.0150748489846205	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	FCRL3; TLR9; SLAMF8;	GO:0045577~regulation of B cell differentiation	3	10	30	0.0150748489846205	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	EREG; TGFA; ADRA2A;	GO:0045741~positive regulation of epidermal growth factor-activated receptor activity	3	10	30	0.0150748489846205	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	EGFR; REEP1; RTP5;	GO:0051205~protein insertion into membrane	3	10	30	0.0150748489846205	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	DCN; ALOX12; KDR;	GO:0051901~positive regulation of mitochondrial depolarization	3	10	30	0.0150748489846205	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	CDK1; CCNB1; HEY2;	GO:0055015~ventricular cardiac muscle cell development	3	10	30	0.0150748489846205	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	SLC1A3; SLC1A1; CXADR;	GO:0070633~transepithelial transport	3	10	30	0.0150748489846205	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	ANXA1; KIT; CXADR; CDC42BPG; GPR65; TRPV4; PARVG;	GO:0031532~actin cytoskeleton reorganization	7	56	12.5	0.0155857012695719	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	CKB; MAOB; YWHAE; DYNLL1; INA; NDRG2;	GO:0021762~substantia nigra development	6	43	13.953488372093	0.0156796044554539	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	CTNND1; CDH1; JUP; DSP; NECTIN1; CDH26;	GO:0034332~adherens junction organization	6	43	13.953488372093	0.0156796044554539	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	PRL; GJA1; XDH; SULF1; ATOH8;	GO:0001937~negative regulation of endothelial cell proliferation	5	31	16.1290322580645	0.0160593380755192	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	CCNE1; POLE2; CDC6; CDC45; MCM10;	GO:0006270~DNA replication initiation	5	31	16.1290322580645	0.0160593380755192	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	FST; SOSTDC1; SHROOM3; FOXJ1; EYA1;	GO:0007389~pattern specification process	5	31	16.1290322580645	0.0160593380755192	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	EGFR; NTRK1; KDR; PTK6; SLA;	GO:0038083~peptidyl-tyrosine autophosphorylation	5	31	16.1290322580645	0.0160593380755192	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	EGFR; SRD5A1; GJB2; ERRFI1; PCK2;	GO:0071549~cellular response to dexamethasone stimulus	5	31	16.1290322580645	0.0160593380755192	0.117820200116047	1	1	0.999989987113883	0.999989987113883	1
down	RAMP2; TOM1L1; NGFR; CLTB; TOM1L2; RIMS1; EXPH5; SYTL5; SYTL4; SORCS2; COPZ2; MYO6; RAB27B; TBC1D3E; RAB11A; RAB9A; GRTP1; ARL4D; STX19; RAB10; TMED3; USP6NL; RAB39A;	GO:0006886~intracellular protein transport	23	317	7.25552050473186	0.0163300976085244	0.118361211233826	1	1	0.999989987113883	0.999989987113883	1
down	EREG; CCNB1; TRIP13; RXFP2;	GO:0001556~oocyte maturation	4	20	20	0.0163668926859768	0.118361211233826	1	1	0.999989987113883	0.999989987113883	1
down	EPHB3; SEMA3A; NDN; CRTAC1;	GO:0007413~axonal fasciculation	4	20	20	0.0163668926859768	0.118361211233826	1	1	0.999989987113883	0.999989987113883	1
down	BMP4; PAX9; MIXL1; EPB41L5;	GO:0007492~endoderm development	4	20	20	0.0163668926859768	0.118361211233826	1	1	0.999989987113883	0.999989987113883	1
down	GREM1; RARB; BMP4; RARG;	GO:0032331~negative regulation of chondrocyte differentiation	4	20	20	0.0163668926859768	0.118361211233826	1	1	0.999989987113883	0.999989987113883	1
down	CRHBP; RAB10; RIMS1; TMEM79;	GO:0045055~regulated exocytosis	4	20	20	0.0163668926859768	0.118361211233826	1	1	0.999989987113883	0.999989987113883	1
down	CCL24; LGALS3; CX3CL1; XCL2;	GO:0048245~eosinophil chemotaxis	4	20	20	0.0163668926859768	0.118361211233826	1	1	0.999989987113883	0.999989987113883	1
down	KCNQ1; ANK2; SCN5A; KCNE1B;	GO:0060307~regulation of ventricular cardiac muscle cell membrane repolarization	4	20	20	0.0163668926859768	0.118361211233826	1	1	0.999989987113883	0.999989987113883	1
down	EGFR; GJA1; ALOX12; PPARD;	GO:0097755~positive regulation of blood vessel diameter	4	20	20	0.0163668926859768	0.118361211233826	1	1	0.999989987113883	0.999989987113883	1
down	PLD2; PLD1; KNDC1; DOCK3; RAPGEF4; RAPGEF5; RERG; RAPGEFL1; ARHGAP32;	GO:0007264~small GTPase mediated signal transduction	9	85	10.5882352941176	0.0165452920926147	0.119272706920811	1	1	0.999989987113883	0.999989987113883	1
down	BMP4; BMP7; FST; SOSTDC1; DSG4; CHRDL1; BMP3; LEFTY1; RGMA;	GO:0030509~BMP signaling pathway	9	85	10.5882352941176	0.0165452920926147	0.119272706920811	1	1	0.999989987113883	0.999989987113883	1
down	ADCY5; GM2A; SLC1A3; TIFAB; GPR88; SHANK1;	GO:0050885~neuromuscular process controlling balance	6	44	13.6363636363636	0.0172070420468557	0.123651866822515	1	1	0.999989987113883	0.999989987113883	1
down	NTRK1; MS4A1; VCAM1; CD40LG; FLT3; HHEX; BLNK; KIT;	GO:0030183~B cell differentiation	8	72	11.1111111111111	0.0182503643776104	0.130377124437214	1	1	0.999989987113883	0.999989987113883	1
down	GINS2; MCM4; CDC45;	GO:0000727~double-strand break repair via break-induced replication	3	11	27.2727272727273	0.0186007749965297	0.130377124437214	1	1	0.999989987113883	0.999989987113883	1
down	SLC26A4; RACGAP1; SLC25A10;	GO:0008272~sulfate transport	3	11	27.2727272727273	0.0186007749965297	0.130377124437214	1	1	0.999989987113883	0.999989987113883	1
down	VIL1; DSTN; TWF1;	GO:0030042~actin filament depolymerization	3	11	27.2727272727273	0.0186007749965297	0.130377124437214	1	1	0.999989987113883	0.999989987113883	1
down	ITPKC; IPPK; PPIP5K1;	GO:0032958~inositol phosphate biosynthetic process	3	11	27.2727272727273	0.0186007749965297	0.130377124437214	1	1	0.999989987113883	0.999989987113883	1
down	CDK1; AURKB; TTK;	GO:0034501~protein localization to kinetochore	3	11	27.2727272727273	0.0186007749965297	0.130377124437214	1	1	0.999989987113883	0.999989987113883	1
down	CRHBP; DLG2; PPARGC1A;	GO:0035865~cellular response to potassium ion	3	11	27.2727272727273	0.0186007749965297	0.130377124437214	1	1	0.999989987113883	0.999989987113883	1
down	EGFR; KIT; WNT10A;	GO:0043586~tongue development	3	11	27.2727272727273	0.0186007749965297	0.130377124437214	1	1	0.999989987113883	0.999989987113883	1
down	SLC12A8; SLC12A1; SLC12A3;	GO:0055064~chloride ion homeostasis	3	11	27.2727272727273	0.0186007749965297	0.130377124437214	1	1	0.999989987113883	0.999989987113883	1
down	HEYL; DLL4; HEY2;	GO:0061314~Notch signaling involved in heart development	3	11	27.2727272727273	0.0186007749965297	0.130377124437214	1	1	0.999989987113883	0.999989987113883	1
down	EFNA5; HMGCS1; PPARGC1A;	GO:0071372~cellular response to follicle-stimulating hormone stimulus	3	11	27.2727272727273	0.0186007749965297	0.130377124437214	1	1	0.999989987113883	0.999989987113883	1
down	RAB27B; EXPH5; SYTL4;	GO:0071985~multivesicular body sorting pathway	3	11	27.2727272727273	0.0186007749965297	0.130377124437214	1	1	0.999989987113883	0.999989987113883	1
down	DSP; PLEKHA7; CAMSAP3;	GO:0090136~epithelial cell-cell adhesion	3	11	27.2727272727273	0.0186007749965297	0.130377124437214	1	1	0.999989987113883	0.999989987113883	1
down	TRPM2; TRPV6; TRPV5;	GO:0098703~calcium ion import across plasma membrane	3	11	27.2727272727273	0.0186007749965297	0.130377124437214	1	1	0.999989987113883	0.999989987113883	1
down	ADCY5; EFNA5; GNAI1;	GO:1904322~cellular response to forskolin	3	11	27.2727272727273	0.0186007749965297	0.130377124437214	1	1	0.999989987113883	0.999989987113883	1
down	GREM1; LOX; FMOD; ADAMTS14; SFRP2; LOXL4;	GO:0030199~collagen fibril organization	6	45	13.3333333333333	0.0188336245592431	0.130558933689185	1	1	0.999989987113883	0.999989987113883	1
down	NCKAP1L; SPNS2; TNFRSF13B; GAPT;	GO:0001782~B cell homeostasis	4	21	19.047619047619	0.0188559654011158	0.130558933689185	1	1	0.999989987113883	0.999989987113883	1
down	FMO1; FMO2; CYP2J2; CYP2E1;	GO:0006082~organic acid metabolic process	4	21	19.047619047619	0.0188559654011158	0.130558933689185	1	1	0.999989987113883	0.999989987113883	1
down	PLPP3; FUT3; FUT6; FUT7;	GO:0006672~ceramide metabolic process	4	21	19.047619047619	0.0188559654011158	0.130558933689185	1	1	0.999989987113883	0.999989987113883	1
down	SCEL; CAMSAP3; STOX2; RAI2;	GO:0009792~embryo development ending in birth or egg hatching	4	21	19.047619047619	0.0188559654011158	0.130558933689185	1	1	0.999989987113883	0.999989987113883	1
down	CXADR; TJP1; MARVELD2; MARVELD3;	GO:0045216~cell-cell junction organization	4	21	19.047619047619	0.0188559654011158	0.130558933689185	1	1	0.999989987113883	0.999989987113883	1
down	SRPX2; ANXA1; KDR; RHOJ;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	4	21	19.047619047619	0.0188559654011158	0.130558933689185	1	1	0.999989987113883	0.999989987113883	1
down	EGFR; TXN; OSM; BDNF; OPRD1; ANGPT1; NTRK2; SFRP2; TNKS1BP1;	GO:0033138~positive regulation of peptidyl-serine phosphorylation	9	88	10.2272727272727	0.0199289830166777	0.137279884117638	1	1	0.999989987113883	0.999989987113883	1
down	DDX11L8; TK1; TPMT; SLC29A2; UPP1;	GO:0006139~nucleobase-containing compound metabolic process	5	33	15.1515151515152	0.0199772965693578	0.137279884117638	1	1	0.999989987113883	0.999989987113883	1
down	THRB; GLP1R; CYP2J2; KCNQ1; HBEGF;	GO:0008016~regulation of heart contraction	5	33	15.1515151515152	0.0199772965693578	0.137279884117638	1	1	0.999989987113883	0.999989987113883	1
down	GPR55; GPR174; GPR65; F2RL3; P2RY10;	GO:0035025~positive regulation of Rho protein signal transduction	5	33	15.1515151515152	0.0199772965693578	0.137279884117638	1	1	0.999989987113883	0.999989987113883	1
down	BMP4; PAX9; AQP3; PITX2; WNT10A;	GO:0042476~odontogenesis	5	33	15.1515151515152	0.0199772965693578	0.137279884117638	1	1	0.999989987113883	0.999989987113883	1
down	BDNF; GJB2; SOX2; KCNQ1; TIFAB; ADGRV1;	GO:0048839~inner ear development	6	46	13.0434782608696	0.020562020663152	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	VEGFD; MET; BMP4; LGALS3; CX3CL1; ANGPT1;	GO:0050918~positive chemotaxis	6	46	13.0434782608696	0.020562020663152	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	DOC2B; DHCR24; DUOXA1; PHYHIP; CCDC120; WNK4; PARD3; PARD3B;	GO:0008104~protein localization	8	74	10.8108108108108	0.0208818435092427	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	GCNT3; MUC1; GALNT12; MUC20; MUC4; GALNT9; GALNT8;	GO:0016266~O-glycan processing	7	60	11.6666666666667	0.0212562691801488	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	FOXE1; EREG; BIRC5; FOXP2; KLF4; ATP8B1; HR; GREM1; IFNG; BMP4; SPI1; BMP7; PPARG; PAX9; WNT4; SOX8; PITX1; ELF3; HHEX; MECOM; PPARD; RUNX1T1; FOXM1; DEPDC1; KCTD1; BEND5; CIART; SFRP2; ATOH8; SOX7; HEYL; HEY2; TBX21; ZNF488;	GO:0045892~negative regulation of transcription, DNA-templated	34	530	6.41509433962264	0.0212887776623214	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	TRPM2; EDN2; NMU; PPARGC1A;	GO:0001659~temperature homeostasis	4	22	18.1818181818182	0.0215668008860179	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	DCN; STC1; DLL4; ADAMTS9;	GO:0010596~negative regulation of endothelial cell migration	4	22	18.1818181818182	0.0215668008860179	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	NCR1; PRDX1; IL18; ULBP2;	GO:0030101~natural killer cell activation	4	22	18.1818181818182	0.0215668008860179	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	IFNG; BMP4; SPI1; CEBPE;	GO:0030225~macrophage differentiation	4	22	18.1818181818182	0.0215668008860179	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	MET; BMP4; BMP7; RASIP1;	GO:0048754~branching morphogenesis of an epithelial tube	4	22	18.1818181818182	0.0215668008860179	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	PRODH; DKK1; BMP4; AKR1C3; HBA1;	GO:0010942~positive regulation of cell death	5	34	14.7058823529412	0.0221511238705424	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	BMP4; BMP7; MSX1; YWHAE; HHEX;	GO:0034504~protein localization to nucleus	5	34	14.7058823529412	0.0221511238705424	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	GJB3; DHCR24; SLC27A4; WNT10A; DSP;	GO:0043588~skin development	5	34	14.7058823529412	0.0221511238705424	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	COBL; SRD5A1; PTN; WNT4; HMGCS1; GNPNAT1; RARB; MET;	GO:0001889~liver development	8	75	10.6666666666667	0.0222936154673199	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	RECQL4; DQX1; GINS2; RAD54B; ANXA1; RECQL5; DDX11L8; PIF1;	GO:0032508~DNA duplex unwinding	8	75	10.6666666666667	0.0222936154673199	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	EREG; GJA1; BMP7; GNAI1; HHEX; ANXA1;	GO:0043434~response to peptide hormone	6	47	12.7659574468085	0.0223947709728732	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	INPP1; PLCD1; INPP5J; PPIP5K1; ITPKC; IPPK;	GO:0043647~inositol phosphate metabolic process	6	47	12.7659574468085	0.0223947709728732	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	PRMT5; FST; WNT4; HOPX; P2RY12; ELF5;	GO:0045596~negative regulation of cell differentiation	6	47	12.7659574468085	0.0223947709728732	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	GINS1; GINS2; MCM4;	GO:0006271~DNA strand elongation involved in DNA replication	3	12	25	0.0225432082322157	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	ADAMTS9; FBXO27; NCCRP1;	GO:0006516~glycoprotein catabolic process	3	12	25	0.0225432082322157	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	HYKK; CRYM; SLC25A21;	GO:0006554~lysine catabolic process	3	12	25	0.0225432082322157	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	ADRA2A; CHRNB4; CNN1;	GO:0006940~regulation of smooth muscle contraction	3	12	25	0.0225432082322157	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	C3; C1QA; CX3CL1;	GO:0016322~neuron remodeling	3	12	25	0.0225432082322157	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	SRD5A1; PTN; OLIG2;	GO:0021794~thalamus development	3	12	25	0.0225432082322157	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	GATA1; SOX8; TMEM119;	GO:0033690~positive regulation of osteoblast proliferation	3	12	25	0.0225432082322157	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	IL18RAP; CXCL6; IL18;	GO:0042119~neutrophil activation	3	12	25	0.0225432082322157	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	DIO2; CHST8; DUOX1;	GO:0042446~hormone biosynthetic process	3	12	25	0.0225432082322157	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	KALRN; DBH; AVPR1A;	GO:0042711~maternal behavior	3	12	25	0.0225432082322157	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	SLC18A1; SLC47A2; SLC47A1;	GO:0042908~xenobiotic transport	3	12	25	0.0225432082322157	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	SCD; SCD5; PPT2;	GO:0046949~fatty-acyl-CoA biosynthetic process	3	12	25	0.0225432082322157	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	SCIN; WIPF3; WASL;	GO:0051127~positive regulation of actin nucleation	3	12	25	0.0225432082322157	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	TLCD2; CETP; TLCD1;	GO:0055091~phospholipid homeostasis	3	12	25	0.0225432082322157	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	NFIA; SEZ6L; SHANK1;	GO:0060074~synapse maturation	3	12	25	0.0225432082322157	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	C3; PPARG; NCKAP1L;	GO:0060100~positive regulation of phagocytosis, engulfment	3	12	25	0.0225432082322157	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	ALOX15B; LPL; AIF1;	GO:0090197~positive regulation of chemokine secretion	3	12	25	0.0225432082322157	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	CEACAM1; ALOX12; CD9;	GO:0090331~negative regulation of platelet aggregation	3	12	25	0.0225432082322157	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	UBE2C; PLK1; CDC20;	GO:1904668~positive regulation of ubiquitin protein ligase activity	3	12	25	0.0225432082322157	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	RAMP2; CEACAM1; KDR;	GO:2001214~positive regulation of vasculogenesis	3	12	25	0.0225432082322157	0.140300021394852	1	1	0.999989987113883	0.999989987113883	1
down	FOXE1; EGFR; TGFA; ERBB2; KIT; TAL1; PPARG; IRX5; IRX3; PPARD; TEAD4; ECM1; NFE4; DMRTC2; ARNTL2; TFAP2C; ISL2; PITX2; RBBP8; SOX7; STOX2; GTF2IRD1; SOX21; VENTX; BARX1; CCNC; BATF; NR2F6; SP6; KLF4; EPAS1; KLF8; FOXA1; KLF5; GRHL1; HOPX; TBL1Y; SPI1; GRHL2; FOXQ1; SPIB; ELF5; EHF; ELF3; BARX2;	GO:0006357~regulation of transcription by RNA polymerase II	45	747	6.02409638554217	0.0234262023558303	0.141176954938046	1	1	0.999989987113883	0.999989987113883	1
down	TNFSF11; EGFR; MGP; BMP7; STC1; GPM6B; ECM1; CHRDL1;	GO:0001503~ossification	8	76	10.5263157894737	0.0237713236850087	0.143067570289167	1	1	0.999989987113883	0.999989987113883	1
down	CHL1; KALRN; SNCG; CSTB; OPRD1; SEZ6L;	GO:0008344~adult locomotory behavior	6	48	12.5	0.0243342816417169	0.146069811804562	1	1	0.999989987113883	0.999989987113883	1
down	EPHA1; EPHB3; TYRO3; LAMC3; PARVG; LAMB4;	GO:0034446~substrate adhesion-dependent cell spreading	6	48	12.5	0.0243342816417169	0.146069811804562	1	1	0.999989987113883	0.999989987113883	1
down	ATP1B1; CNGA1; P2RX1; ANO1; SLC47A1;	GO:0098655~cation transmembrane transport	5	35	14.2857142857143	0.0244726460932991	0.146124465022112	1	1	0.999989987113883	0.999989987113883	1
down	EGFR; CEACAM1; PTPN13; CEP55;	GO:0014066~regulation of phosphatidylinositol 3-kinase signaling	4	23	17.3913043478261	0.0245037513777202	0.146124465022112	1	1	0.999989987113883	0.999989987113883	1
down	KALRN; OPHN1; EPS8L1; EPS8L2;	GO:0035023~regulation of Rho protein signal transduction	4	23	17.3913043478261	0.0245037513777202	0.146124465022112	1	1	0.999989987113883	0.999989987113883	1
down	RAB27B; RAB9A; EXPH5; SYTL4;	GO:0045921~positive regulation of exocytosis	4	23	17.3913043478261	0.0245037513777202	0.146124465022112	1	1	0.999989987113883	0.999989987113883	1
down	EGFR; NTRK1; CCR2; SHANK1;	GO:0051968~positive regulation of synaptic transmission, glutamatergic	4	23	17.3913043478261	0.0245037513777202	0.146124465022112	1	1	0.999989987113883	0.999989987113883	1
down	SOCS6; CCNB2; IFNG; OSM; IGFBP2; IGSF11; NDN;	GO:0040008~regulation of growth	7	62	11.2903225806452	0.0245688634426909	0.14613021128577	1	1	0.999989987113883	0.999989987113883	1
down	SRPX2; NTRK1; BDNF; EFNA5; EPHB3; NTRK2; LINGO2;	GO:0051965~positive regulation of synapse assembly	7	62	11.2903225806452	0.0245688634426909	0.14613021128577	1	1	0.999989987113883	0.999989987113883	1
down	EPHA3; EFNA5; ARHGEF5; GPM6B; BAIAP2; ARHGAP40; RHOJ; ARHGAP28;	GO:0032956~regulation of actin cytoskeleton organization	8	77	10.3896103896104	0.0253163525165404	0.15037979408782	1	1	0.999989987113883	0.999989987113883	1
down	LPL; SDC4; ADH7; AKR1C3; AKR1C1; RDH10; BCO2;	GO:0001523~retinoid metabolic process	7	63	11.1111111111111	0.0263508536542286	0.156104053671809	1	1	0.999989987113883	0.999989987113883	1
down	FDXR; COX7A1; AVPR1A; PHKA1; PPARD; RUNX1T1;	GO:0006091~generation of precursor metabolites and energy	6	49	12.2448979591837	0.0263828185529617	0.156104053671809	1	1	0.999989987113883	0.999989987113883	1
up	CXCL11; S100A6; S100A11; SNX27; PI4KB;	GO:0007165~signal transduction	5	989	0.505561172901921	0.0264493104098265	0.0635268682960785	1	1	0.617822226846541	0.618845478388709	0.3947426138313
down	GSTP1; NUDT15; PPARGC1A;	GO:0000302~response to reactive oxygen species	3	13	23.0769230769231	0.0269029053542709	0.156383004610442	1	1	0.999989987113883	0.999989987113883	1
down	GREM1; EPHA3; PHLDB2;	GO:0010717~regulation of epithelial to mesenchymal transition	3	13	23.0769230769231	0.0269029053542709	0.156383004610442	1	1	0.999989987113883	0.999989987113883	1
down	C3; LPL; HILPDA;	GO:0010884~positive regulation of lipid storage	3	13	23.0769230769231	0.0269029053542709	0.156383004610442	1	1	0.999989987113883	0.999989987113883	1
down	IGFBP5; PPARD; PPARGC1A;	GO:0014912~negative regulation of smooth muscle cell migration	3	13	23.0769230769231	0.0269029053542709	0.156383004610442	1	1	0.999989987113883	0.999989987113883	1
down	CD19; FCGR2B; TLR8;	GO:0016064~immunoglobulin mediated immune response	3	13	23.0769230769231	0.0269029053542709	0.156383004610442	1	1	0.999989987113883	0.999989987113883	1
down	RAMP2; CEACAM1; ANGPT1;	GO:0043116~negative regulation of vascular permeability	3	13	23.0769230769231	0.0269029053542709	0.156383004610442	1	1	0.999989987113883	0.999989987113883	1
down	CCR2; SPINK5; TBX21;	GO:0045580~regulation of T cell differentiation	3	13	23.0769230769231	0.0269029053542709	0.156383004610442	1	1	0.999989987113883	0.999989987113883	1
down	WNT4; MYOCD; HEY2;	GO:0051145~smooth muscle cell differentiation	3	13	23.0769230769231	0.0269029053542709	0.156383004610442	1	1	0.999989987113883	0.999989987113883	1
down	SPTA1; VIL1; SCIN;	GO:0051693~actin filament capping	3	13	23.0769230769231	0.0269029053542709	0.156383004610442	1	1	0.999989987113883	0.999989987113883	1
down	STC1; ANK2; SCN5A;	GO:0086004~regulation of cardiac muscle cell contraction	3	13	23.0769230769231	0.0269029053542709	0.156383004610442	1	1	0.999989987113883	0.999989987113883	1
down	KIT; GATA1; PPARGC1A;	GO:0097067~cellular response to thyroid hormone stimulus	3	13	23.0769230769231	0.0269029053542709	0.156383004610442	1	1	0.999989987113883	0.999989987113883	1
down	USP6NL; EHD3; CAMSAP3;	GO:1903358~regulation of Golgi organization	3	13	23.0769230769231	0.0269029053542709	0.156383004610442	1	1	0.999989987113883	0.999989987113883	1
down	GATA1; MSX1; HEY2;	GO:2000678~negative regulation of transcription regulatory region DNA binding	3	13	23.0769230769231	0.0269029053542709	0.156383004610442	1	1	0.999989987113883	0.999989987113883	1
down	ANXA1; CCR2; SLC7A2; NLRP6; DUOXA1; ABHD12; MGLL; IL1RL2;	GO:0050727~regulation of inflammatory response	8	78	10.2564102564103	0.026930041937801	0.156383004610442	1	1	0.999989987113883	0.999989987113883	1
down	LPL; PPARG; HSPA2; LRP11; PPARGC1A;	GO:0009409~response to cold	5	36	13.8888888888889	0.0269448328839327	0.156383004610442	1	1	0.999989987113883	0.999989987113883	1
down	HSPA2; CCNA1; TRIP13; DMRTC2;	GO:0007141~male meiosis I	4	24	16.6666666666667	0.0276703775855671	0.159779772217799	1	1	0.999989987113883	0.999989987113883	1
down	HPN; FOXA1; VASN; SFRP2;	GO:0010719~negative regulation of epithelial to mesenchymal transition	4	24	16.6666666666667	0.0276703775855671	0.159779772217799	1	1	0.999989987113883	0.999989987113883	1
down	BDKRB2; PLA2G4A; PLA2G2D; ANXA1;	GO:0050482~arachidonic acid secretion	4	24	16.6666666666667	0.0276703775855671	0.159779772217799	1	1	0.999989987113883	0.999989987113883	1
down	ATP1B1; KEL; CCR2; STC1; ANK2; TRPV4; ATP13A4; ATP13A5; ATP2C2;	GO:0006874~cellular calcium ion homeostasis	9	94	9.57446808510638	0.0281458567557312	0.162114441692935	1	1	0.999989987113883	0.999989987113883	1
down	GSTP1; CEACAM1; GOT1; SRD5A1; PPARG; RAB10; SORBS1; ERRFI1; PCK2;	GO:0032869~cellular response to insulin stimulus	9	94	9.57446808510638	0.0281458567557312	0.162114441692935	1	1	0.999989987113883	0.999989987113883	1
down	GREM1; SASH1; EGFR; MMP8; IL18; TLR9; TLR7;	GO:1901224~positive regulation of NIK/NF-kappaB signaling	7	64	10.9375	0.0282188659100016	0.162329738744908	1	1	0.999989987113883	0.999989987113883	1
down	E2F8; GJB3; DCN; PPARG; PHLDA2;	GO:0001890~placenta development	5	37	13.5135135135135	0.0295703452116328	0.166273584526775	1	1	0.999989987113883	0.999989987113883	1
down	CLIC3; ANO1; WNK4; TTYH1; NMUR1;	GO:0006821~chloride transport	5	37	13.5135135135135	0.0295703452116328	0.166273584526775	1	1	0.999989987113883	0.999989987113883	1
down	EREG; ADRA2A; HHLA2; HILPDA;	GO:0001819~positive regulation of cytokine production	4	25	16	0.0310694637982982	0.166273584526775	1	1	0.999989987113883	0.999989987113883	1
down	TMEM246; PIGW; CWH43; PIGN;	GO:0006506~GPI anchor biosynthetic process	4	25	16	0.0310694637982982	0.166273584526775	1	1	0.999989987113883	0.999989987113883	1
down	CYP2E1; TPMT; FMO1; FMO2;	GO:0017144~drug metabolic process	4	25	16	0.0310694637982982	0.166273584526775	1	1	0.999989987113883	0.999989987113883	1
down	CYP4B1; NUDT15; CYP2J2; CYP2E1;	GO:0042738~exogenous drug catabolic process	4	25	16	0.0310694637982982	0.166273584526775	1	1	0.999989987113883	0.999989987113883	1
down	SDC4; KDR; WNT4; EPB41L5;	GO:0051894~positive regulation of focal adhesion assembly	4	25	16	0.0310694637982982	0.166273584526775	1	1	0.999989987113883	0.999989987113883	1
down	VCAM1; ITGB8; EMP2; NPNT; MUC4; SORBS1; PARVG; LYVE1; COL19A1;	GO:0007160~cell-matrix adhesion	9	96	9.375	0.0313466815044943	0.166273584526775	1	1	0.999989987113883	0.999989987113883	1
down	PRODH; MELK; GSKIP;	GO:0008631~intrinsic apoptotic signaling pathway in response to oxidative stress	3	14	21.4285714285714	0.031678110484908	0.166273584526775	1	1	0.999989987113883	0.999989987113883	1
down	FUT3; ST6GALNAC1; B3GALT5;	GO:0009312~oligosaccharide biosynthetic process	3	14	21.4285714285714	0.031678110484908	0.166273584526775	1	1	0.999989987113883	0.999989987113883	1
down	HBZ; HBD; HBA1;	GO:0015671~oxygen transport	3	14	21.4285714285714	0.031678110484908	0.166273584526775	1	1	0.999989987113883	0.999989987113883	1
down	PPARG; SLC27A4; SLC27A6;	GO:0015909~long-chain fatty acid transport	3	14	21.4285714285714	0.031678110484908	0.166273584526775	1	1	0.999989987113883	0.999989987113883	1
down	NPR1; NPR3; BTC;	GO:0035810~positive regulation of urine volume	3	14	21.4285714285714	0.031678110484908	0.166273584526775	1	1	0.999989987113883	0.999989987113883	1
down	CRHBP; FOXA1; WNT4;	GO:0042445~hormone metabolic process	3	14	21.4285714285714	0.031678110484908	0.166273584526775	1	1	0.999989987113883	0.999989987113883	1
down	EGFR; EPHB3; SFRP2;	GO:0048546~digestive tract morphogenesis	3	14	21.4285714285714	0.031678110484908	0.166273584526775	1	1	0.999989987113883	0.999989987113883	1
down	FOXP2; BMP4; DLG1;	GO:0048745~smooth muscle tissue development	3	14	21.4285714285714	0.031678110484908	0.166273584526775	1	1	0.999989987113883	0.999989987113883	1
down	WNT10B; SCNN1A; SCNN1B;	GO:0050909~sensory perception of taste	3	14	21.4285714285714	0.031678110484908	0.166273584526775	1	1	0.999989987113883	0.999989987113883	1
down	TRIM16; SRD5A1; IGFBP5;	GO:0060416~response to growth hormone	3	14	21.4285714285714	0.031678110484908	0.166273584526775	1	1	0.999989987113883	0.999989987113883	1
down	ATP1B1; GJA1; PKP2;	GO:0086064~cell communication by electrical coupling involved in cardiac conduction	3	14	21.4285714285714	0.031678110484908	0.166273584526775	1	1	0.999989987113883	0.999989987113883	1
up	TSPAN8; ODF3; TDRKH;	GO:0007283~spermatogenesis	3	407	0.737100737100737	0.0321266314916473	0.0697322233927228	1	1	0.618845478388709	0.618845478388709	0.433301386777329
down	PLD2; PLCD1; PLD1; LIPN; ASPG; LIPH; PLA2G2D; LPL;	GO:0016042~lipid catabolic process	8	81	9.87654320987654	0.0321957575345512	0.16872464083929	1	1	0.999989987113883	0.999989987113883	1
down	CDK1; TOP2A; PPARG; MAPK10; PRKAA2; HLF; DTL;	GO:0048511~rhythmic process	7	66	10.6060606060606	0.032219147833666	0.16872464083929	1	1	0.999989987113883	0.999989987113883	1
down	LOX; EPHA2; KDR; TYRO3; P2RY12;	GO:0043491~protein kinase B signaling	5	38	13.1578947368421	0.0323515316623577	0.169223396387717	1	1	0.999989987113883	0.999989987113883	1
down	SEMG1; BPI; PRSS3; DEFB1; LCN2; RNASE6;	GO:0019730~antimicrobial humoral response	6	52	11.5384615384615	0.0332030362385367	0.173279533909248	1	1	0.999989987113883	0.999989987113883	1
down	EPHA1; SDC4; WNT4; ARHGEF5; GPR65; LIMCH1;	GO:0051496~positive regulation of stress fiber assembly	6	52	11.5384615384615	0.0332030362385367	0.173279533909248	1	1	0.999989987113883	0.999989987113883	1
down	OIP5; GJB3; TRIP10; GJA3;	GO:0007154~cell communication	4	26	15.3846153846154	0.0347030367769131	0.180076350291135	1	1	0.999989987113883	0.999989987113883	1
down	TPPP; GSTP1; CD9; ZNF488;	GO:0014003~oligodendrocyte development	4	26	15.3846153846154	0.0347030367769131	0.180076350291135	1	1	0.999989987113883	0.999989987113883	1
down	EYA1; CASZ1; LTK; BDNF;	GO:0045664~regulation of neuron differentiation	4	26	15.3846153846154	0.0347030367769131	0.180076350291135	1	1	0.999989987113883	0.999989987113883	1
down	RGS4; RIMS1; BAIAP2; SHANK1;	GO:2000463~positive regulation of excitatory postsynaptic potential	4	26	15.3846153846154	0.0347030367769131	0.180076350291135	1	1	0.999989987113883	0.999989987113883	1
down	SOCS6; RGS20; RGS11; ERBB3; PTK6;	GO:0009968~negative regulation of signal transduction	5	39	12.8205128205128	0.0352904262205114	0.182500773962145	1	1	0.999989987113883	0.999989987113883	1
down	GSTP1; BMP4; BMP7; CD300A; SPRY1;	GO:0043407~negative regulation of MAP kinase activity	5	39	12.8205128205128	0.0352904262205114	0.182500773962145	1	1	0.999989987113883	0.999989987113883	1
down	EGFR; MT1E; MT1G; AKR1C3; MT1H;	GO:0071276~cellular response to cadmium ion	5	39	12.8205128205128	0.0352904262205114	0.182500773962145	1	1	0.999989987113883	0.999989987113883	1
down	CD3G; DLG1; MAP7; PARD3; RHOJ; PARVG;	GO:0007163~establishment or maintenance of cell polarity	6	53	11.3207547169811	0.0357073615764665	0.184447550274809	1	1	0.999989987113883	0.999989987113883	1
down	LPL; CETP; FGFR4; CD24; EPHX2; AKR1C1; IL18; CYP7B1;	GO:0042632~cholesterol homeostasis	8	83	9.63855421686747	0.0360718936666228	0.186119532893696	1	1	0.999989987113883	0.999989987113883	1
down	BMP4; HEYL; HEY2;	GO:0003184~pulmonary valve morphogenesis	3	15	20	0.0368648347799647	0.186617985841688	1	1	0.999989987113883	0.999989987113883	1
down	ALOX12; PPARG; PPARGC1A;	GO:0019395~fatty acid oxidation	3	15	20	0.0368648347799647	0.186617985841688	1	1	0.999989987113883	0.999989987113883	1
down	WNT1; CDH1; EPB41L5;	GO:0022408~negative regulation of cell-cell adhesion	3	15	20	0.0368648347799647	0.186617985841688	1	1	0.999989987113883	0.999989987113883	1
down	SKA3; SKA2; SKA1;	GO:0031110~regulation of microtubule polymerization or depolymerization	3	15	20	0.0368648347799647	0.186617985841688	1	1	0.999989987113883	0.999989987113883	1
down	TLR8; TLR7; TLR9;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	3	15	20	0.0368648347799647	0.186617985841688	1	1	0.999989987113883	0.999989987113883	1
down	IFNG; IL2RA; CTLA4;	GO:0045589~regulation of regulatory T cell differentiation	3	15	20	0.0368648347799647	0.186617985841688	1	1	0.999989987113883	0.999989987113883	1
down	ABHD12; GDPD3; PLA2G4A;	GO:0046475~glycerophospholipid catabolic process	3	15	20	0.0368648347799647	0.186617985841688	1	1	0.999989987113883	0.999989987113883	1
down	DBH; CRHBP; UNC79;	GO:0048149~behavioral response to ethanol	3	15	20	0.0368648347799647	0.186617985841688	1	1	0.999989987113883	0.999989987113883	1
down	UNC13B; PPFIA3; SHISA7;	GO:0048172~regulation of short-term neuronal synaptic plasticity	3	15	20	0.0368648347799647	0.186617985841688	1	1	0.999989987113883	0.999989987113883	1
down	KRT1; RRM2; FARSB;	GO:0051290~protein heterotetramerization	3	15	20	0.0368648347799647	0.186617985841688	1	1	0.999989987113883	0.999989987113883	1
down	MEIS1; GJA1; CXADR;	GO:0060044~negative regulation of cardiac muscle cell proliferation	3	15	20	0.0368648347799647	0.186617985841688	1	1	0.999989987113883	0.999989987113883	1
down	BMP4; FOXA1; ESRP2;	GO:0060441~epithelial tube branching involved in lung morphogenesis	3	15	20	0.0368648347799647	0.186617985841688	1	1	0.999989987113883	0.999989987113883	1
down	SRPX2; MYH14; SHANK1;	GO:0071625~vocalization behavior	3	15	20	0.0368648347799647	0.186617985841688	1	1	0.999989987113883	0.999989987113883	1
down	PRDX1; DLG1; UACA;	GO:1901222~regulation of NIK/NF-kappaB signaling	3	15	20	0.0368648347799647	0.186617985841688	1	1	0.999989987113883	0.999989987113883	1
down	KLF4; KLF5; ANO1;	GO:1901653~cellular response to peptide	3	15	20	0.0368648347799647	0.186617985841688	1	1	0.999989987113883	0.999989987113883	1
down	NIPAL1; ZDHHC13; NIPAL2;	GO:1903830~magnesium ion transmembrane transport	3	15	20	0.0368648347799647	0.186617985841688	1	1	0.999989987113883	0.999989987113883	1
down	CCL21; AIF1; CCL20;	GO:2000406~positive regulation of T cell migration	3	15	20	0.0368648347799647	0.186617985841688	1	1	0.999989987113883	0.999989987113883	1
down	WNT10B; SRD5A1; CRHBP; IGFBP5; KCNQ1; STC1;	GO:0071320~cellular response to cAMP	6	54	11.1111111111111	0.0383297767516835	0.189547238770144	1	1	0.999989987113883	0.999989987113883	1
down	NTRK1; PSPH; PPARG; PRL; PPARD;	GO:0031667~response to nutrient levels	5	40	12.5	0.0383887474508071	0.189547238770144	1	1	0.999989987113883	0.999989987113883	1
down	PLK1; CEP55; NPNT; PHLDB2; ADGRV1;	GO:0045184~establishment of protein localization	5	40	12.5	0.0383887474508071	0.189547238770144	1	1	0.999989987113883	0.999989987113883	1
down	SLC27A2; CYP7B1; OSBPL6; HSD3B7;	GO:0006699~bile acid biosynthetic process	4	27	14.8148148148148	0.0385723878601287	0.189547238770144	1	1	0.999989987113883	0.999989987113883	1
down	GLP1R; DEFB1; ADGRG6; RAPGEF4;	GO:0019933~cAMP-mediated signaling	4	27	14.8148148148148	0.0385723878601287	0.189547238770144	1	1	0.999989987113883	0.999989987113883	1
down	FCN1; EMP2; ANK2; ANGPT1;	GO:0034394~protein localization to cell surface	4	27	14.8148148148148	0.0385723878601287	0.189547238770144	1	1	0.999989987113883	0.999989987113883	1
down	DBI; PLA2G4A; MBOAT2; PLA2G2D;	GO:0036151~phosphatidylcholine acyl-chain remodeling	4	27	14.8148148148148	0.0385723878601287	0.189547238770144	1	1	0.999989987113883	0.999989987113883	1
down	CTNND1; PLEKHA7; CDH26; CDH1;	GO:0044331~cell-cell adhesion mediated by cadherin	4	27	14.8148148148148	0.0385723878601287	0.189547238770144	1	1	0.999989987113883	0.999989987113883	1
down	SRPX2; EPHA2; PLD1; PLD2;	GO:0048870~cell motility	4	27	14.8148148148148	0.0385723878601287	0.189547238770144	1	1	0.999989987113883	0.999989987113883	1
down	CDK1; NGFR; PLK1; GTSE1;	GO:1900182~positive regulation of protein localization to nucleus	4	27	14.8148148148148	0.0385723878601287	0.189547238770144	1	1	0.999989987113883	0.999989987113883	1
down	FOXP2; WDR62; SRD5A1; YWHAE; NTRK2; GNG12; TACC2;	GO:0021987~cerebral cortex development	7	69	10.1449275362319	0.0389011513149986	0.189547238770144	1	1	0.999989987113883	0.999989987113883	1
down	RAD51; INO80C; RAD54L; PIF1; EXO1; RECQL5; RECQL4;	GO:0006310~DNA recombination	7	70	10	0.0413151867861996	0.19051820951207	1	1	0.999989987113883	0.999989987113883	1
down	SSTR3; PPARG; LRP11; PPARGC1A; PCK2;	GO:0042594~response to starvation	5	41	12.1951219512195	0.0416478989948759	0.191858268777204	1	1	0.999989987113883	0.999989987113883	1
down	DLG1; NOX5; PROK2;	GO:0001935~endothelial cell proliferation	3	16	18.75	0.0424571141111074	0.192280926332212	1	1	0.999989987113883	0.999989987113883	1
down	AURKA; BMP4; HEY2;	GO:0009948~anterior/posterior axis specification	3	16	18.75	0.0424571141111074	0.192280926332212	1	1	0.999989987113883	0.999989987113883	1
down	MT1E; MT1H; MT1G;	GO:0010273~detoxification of copper ion	3	16	18.75	0.0424571141111074	0.192280926332212	1	1	0.999989987113883	0.999989987113883	1
down	CSTA; CSTB; ECM1;	GO:0010466~negative regulation of peptidase activity	3	16	18.75	0.0424571141111074	0.192280926332212	1	1	0.999989987113883	0.999989987113883	1
down	CCL21; CCR2; XCL2;	GO:0010820~positive regulation of T cell chemotaxis	3	16	18.75	0.0424571141111074	0.192280926332212	1	1	0.999989987113883	0.999989987113883	1
down	ADRA2A; EDN2; BDKRB2;	GO:0019229~regulation of vasoconstriction	3	16	18.75	0.0424571141111074	0.192280926332212	1	1	0.999989987113883	0.999989987113883	1
down	ALOX15B; HPGD; ALOX12;	GO:0019372~lipoxygenase pathway	3	16	18.75	0.0424571141111074	0.192280926332212	1	1	0.999989987113883	0.999989987113883	1
down	HMMR; CEMIP; LYVE1;	GO:0030214~hyaluronan catabolic process	3	16	18.75	0.0424571141111074	0.192280926332212	1	1	0.999989987113883	0.999989987113883	1
down	GREM1; GATA1; ECM1;	GO:0030502~negative regulation of bone mineralization	3	16	18.75	0.0424571141111074	0.192280926332212	1	1	0.999989987113883	0.999989987113883	1
down	BMP7; STC1; AQP3;	GO:0033280~response to vitamin D	3	16	18.75	0.0424571141111074	0.192280926332212	1	1	0.999989987113883	0.999989987113883	1
down	BMP7; CEACAM6; SKAP1;	GO:0034116~positive regulation of heterotypic cell-cell adhesion	3	16	18.75	0.0424571141111074	0.192280926332212	1	1	0.999989987113883	0.999989987113883	1
down	TLR9; TLR8; TLR7;	GO:0034162~toll-like receptor 9 signaling pathway	3	16	18.75	0.0424571141111074	0.192280926332212	1	1	0.999989987113883	0.999989987113883	1
down	FOXA1; EYA1; ISL2;	GO:0048665~neuron fate specification	3	16	18.75	0.0424571141111074	0.192280926332212	1	1	0.999989987113883	0.999989987113883	1
down	DOC2B; RIMS1; SYT8;	GO:0048791~calcium ion-regulated exocytosis of neurotransmitter	3	16	18.75	0.0424571141111074	0.192280926332212	1	1	0.999989987113883	0.999989987113883	1
down	NTRK1; NR2F6; ANO1;	GO:0050965~detection of temperature stimulus involved in sensory perception of pain	3	16	18.75	0.0424571141111074	0.192280926332212	1	1	0.999989987113883	0.999989987113883	1
down	SLC12A3; SLC12A1; SLC12A8;	GO:0055075~potassium ion homeostasis	3	16	18.75	0.0424571141111074	0.192280926332212	1	1	0.999989987113883	0.999989987113883	1
down	HAAO; CX3CL1; TYRO3;	GO:0070050~neuron cellular homeostasis	3	16	18.75	0.0424571141111074	0.192280926332212	1	1	0.999989987113883	0.999989987113883	1
down	BMP4; HEYL; DLL4; HEY2;	GO:0003180~aortic valve morphogenesis	4	28	14.2857142857143	0.0426780977654706	0.192707049969756	1	1	0.999989987113883	0.999989987113883	1
down	C3; FLT4; CXCL17; SULF1;	GO:0010575~positive regulation of vascular endothelial growth factor production	4	28	14.2857142857143	0.0426780977654706	0.192707049969756	1	1	0.999989987113883	0.999989987113883	1
down	EREG; AURKA; TGFA; BTC;	GO:0045840~positive regulation of mitotic nuclear division	4	28	14.2857142857143	0.0426780977654706	0.192707049969756	1	1	0.999989987113883	0.999989987113883	1
down	TNFSF15; NGFR; PPARG; XDH; P2RX1; FAM162A; EGLN3; BCL2L10;	GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process	8	87	9.19540229885057	0.0447391699989526	0.201813523282404	1	1	0.999989987113883	0.999989987113883	1
down	EGFR; BMP7; DLL4; HEY2; NOTCH3;	GO:0045746~negative regulation of Notch signaling pathway	5	42	11.9047619047619	0.0450689712959188	0.202899439944868	1	1	0.999989987113883	0.999989987113883	1
down	ALOX15B; BMP4; HPGD; BMP7; LILRB1;	GO:0045786~negative regulation of cell cycle	5	42	11.9047619047619	0.0450689712959188	0.202899439944868	1	1	0.999989987113883	0.999989987113883	1
down	IFNG; HLA-DQA2; HLA-DQB2; VCAM1; IRF8; IRF4; FCGR1B;	GO:0060333~interferon-gamma-mediated signaling pathway	7	72	9.72222222222222	0.0464295894946216	0.208612632877215	1	1	0.999989987113883	0.999989987113883	1
down	PLPP3; LPL; PLA2G4A; PLCD1; PLA2G2D; GDPD3;	GO:0006644~phospholipid metabolic process	6	57	10.5263157894737	0.0469180904060795	0.208794746438431	1	1	0.999989987113883	0.999989987113883	1
down	FZD6; NTN1; WNT1; PRRX1; TIFAB; MYO6;	GO:0042472~inner ear morphogenesis	6	57	10.5263157894737	0.0469180904060795	0.208794746438431	1	1	0.999989987113883	0.999989987113883	1
down	BMP4; BMP7; FST; MSX1; SCN5A; SOSTDC1;	GO:0042475~odontogenesis of dentin-containing tooth	6	57	10.5263157894737	0.0469180904060795	0.208794746438431	1	1	0.999989987113883	0.999989987113883	1
down	PTGES; MT-CYB; EGFR; SLC6A1; AQP3; TRPV6;	GO:0051592~response to calcium ion	6	57	10.5263157894737	0.0469180904060795	0.208794746438431	1	1	0.999989987113883	0.999989987113883	1
down	CD1B; CD1C; CD1E; CD1A;	GO:0001916~positive regulation of T cell mediated cytotoxicity	4	29	13.7931034482759	0.0470200636184877	0.208794746438431	1	1	0.999989987113883	0.999989987113883	1
down	RIMS1; RAPGEF4; SCIN; SYT8;	GO:0017156~calcium-ion regulated exocytosis	4	29	13.7931034482759	0.0470200636184877	0.208794746438431	1	1	0.999989987113883	0.999989987113883	1
down	NFASC; VCAM1; ITGAD; LILRB2;	GO:0034113~heterotypic cell-cell adhesion	4	29	13.7931034482759	0.0470200636184877	0.208794746438431	1	1	0.999989987113883	0.999989987113883	1
down	CDKN2B; PLK1; HHEX; MYOCD;	GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity	4	29	13.7931034482759	0.0470200636184877	0.208794746438431	1	1	0.999989987113883	0.999989987113883	1
down	EREG; EGFR; CDK1; CDT1;	GO:0045740~positive regulation of DNA replication	4	29	13.7931034482759	0.0470200636184877	0.208794746438431	1	1	0.999989987113883	0.999989987113883	1
down	EGFR; PTPN3; DLG1; BTG3;	GO:0045930~negative regulation of mitotic cell cycle	4	29	13.7931034482759	0.0470200636184877	0.208794746438431	1	1	0.999989987113883	0.999989987113883	1
down	TPPP; ERBB2; SOX8; NTRK2;	GO:0048709~oligodendrocyte differentiation	4	29	13.7931034482759	0.0470200636184877	0.208794746438431	1	1	0.999989987113883	0.999989987113883	1
down	MT1G; AOC1; MT1H; MT1E;	GO:0071280~cellular response to copper ion	4	29	13.7931034482759	0.0470200636184877	0.208794746438431	1	1	0.999989987113883	0.999989987113883	1
down	ECM1; SULF1; SFRP2;	GO:0002063~chondrocyte development	3	17	17.6470588235294	0.0484472463181371	0.211625747100127	1	1	0.999989987113883	0.999989987113883	1
down	VIT; MATN2; VWA1;	GO:0003429~growth plate cartilage chondrocyte morphogenesis	3	17	17.6470588235294	0.0484472463181371	0.211625747100127	1	1	0.999989987113883	0.999989987113883	1
down	FOXE1; DIO2; DUOX1;	GO:0006590~thyroid hormone generation	3	17	17.6470588235294	0.0484472463181371	0.211625747100127	1	1	0.999989987113883	0.999989987113883	1
down	NCAPH; CDCA5; NCAPG;	GO:0007076~mitotic chromosome condensation	3	17	17.6470588235294	0.0484472463181371	0.211625747100127	1	1	0.999989987113883	0.999989987113883	1
down	FCGR2B; P2RY1; MUC4;	GO:0010469~regulation of signaling receptor activity	3	17	17.6470588235294	0.0484472463181371	0.211625747100127	1	1	0.999989987113883	0.999989987113883	1
down	BDNF; TMEM119; MYOCD;	GO:0010832~negative regulation of myotube differentiation	3	17	17.6470588235294	0.0484472463181371	0.211625747100127	1	1	0.999989987113883	0.999989987113883	1
down	KCNK10; KCNK1; KCNK7;	GO:0030322~stabilization of membrane potential	3	17	17.6470588235294	0.0484472463181371	0.211625747100127	1	1	0.999989987113883	0.999989987113883	1
down	MEIS1; KIT; TAL1;	GO:0035855~megakaryocyte development	3	17	17.6470588235294	0.0484472463181371	0.211625747100127	1	1	0.999989987113883	0.999989987113883	1
down	CD40LG; BATF; EXO1;	GO:0045190~isotype switching	3	17	17.6470588235294	0.0484472463181371	0.211625747100127	1	1	0.999989987113883	0.999989987113883	1
down	EGFR; IFNG; C1QA;	GO:0048143~astrocyte activation	3	17	17.6470588235294	0.0484472463181371	0.211625747100127	1	1	0.999989987113883	0.999989987113883	1
down	GATA1; NCKAP1L; ADGRF5;	GO:0048821~erythrocyte development	3	17	17.6470588235294	0.0484472463181371	0.211625747100127	1	1	0.999989987113883	0.999989987113883	1
down	TNFSF11; CCR2; SIRPG;	GO:0050870~positive regulation of T cell activation	3	17	17.6470588235294	0.0484472463181371	0.211625747100127	1	1	0.999989987113883	0.999989987113883	1
down	GNAI1; GPSM2; TPX2;	GO:0060236~regulation of mitotic spindle organization	3	17	17.6470588235294	0.0484472463181371	0.211625747100127	1	1	0.999989987113883	0.999989987113883	1
down	CD9; PPARG; HMGCS1;	GO:0071404~cellular response to low-density lipoprotein particle stimulus	3	17	17.6470588235294	0.0484472463181371	0.211625747100127	1	1	0.999989987113883	0.999989987113883	1
down	DCN; KDR; SPIRE1;	GO:0090141~positive regulation of mitochondrial fission	3	17	17.6470588235294	0.0484472463181371	0.211625747100127	1	1	0.999989987113883	0.999989987113883	1
down	ATP2C2; LGALS3; STC1;	GO:0090280~positive regulation of calcium ion import	3	17	17.6470588235294	0.0484472463181371	0.211625747100127	1	1	0.999989987113883	0.999989987113883	1
down	NEK2; AURKB; PKIB;	GO:1904355~positive regulation of telomere capping	3	17	17.6470588235294	0.0484472463181371	0.211625747100127	1	1	0.999989987113883	0.999989987113883	1
down	MMP8; COL15A1; COL19A1; ADAMTS14; MMP28;	GO:0030574~collagen catabolic process	5	43	11.6279069767442	0.0486527444631997	0.211782285223627	1	1	0.999989987113883	0.999989987113883	1
down	CCL24; BMP4; FLT4; KDR; ECM1; CCL26; VEGFD;	GO:0001938~positive regulation of endothelial cell proliferation	7	73	9.58904109589041	0.0491317069716772	0.211782285223627	1	1	0.999989987113883	0.999989987113883	1
